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The scientific background and current state of research: 
In the last decades, the frequency of invasive mycoses is on a rise. Among fungi, C. albicans is 
the most common pathogen in bloodstream infection, associated with a high morbidity and 
mortality rate. 
Beside its well-known characteristics in embryogenesis, reproduction and maintenance of the 
human body tissues, vitamin A and its nuclear receptors (NR1B1, NR1B2 and NR1B3) have 
shown important immunomodulatory effects in the innate and adaptive immune response. In 
infectious diseases, treatment with vitamin A has been shown to be host protective in infections 
of viral, bacterial and protozoan origin. Nevertheless, nothing is known about its impact in 
fungal infections. Whereas certain nuclear receptors such as PPARs (NR1C1, NR1C2 and 
NR1C3), GR (NR3C1), ERs (NR3A1 and NR3A2) and the VDR (NR1I1) have already shown 
to have an influence on the outcome of fungal infections, the potential immunomodulatory role 
of vitamin A is largely unknown.  
Interrogation and targets:  
In our present work, we investigate the role of all-trans retinoic acid (atRA), the most active 
metabolite of vitamin A, on the innate immune response against C. albicans in human 
monocytes.  
Methods:  
Human monocytes were treated with UV-killed C. albicans yeasts.   
We analyzed the expression of the cytokines TNFα, IL6, IL12b, IL10 and the PRRs Dectin-1, 
TLR2 and Gal-3 on transcriptional and post-translational level by real-time qPCR, ELISA and 
flow cytometry. Furthermore, we analyzed the role of vitamin A on the specific Dectin-1-
induced antifungal immune response after stimulating monocytes with the Dectin-1 ligand β-
1.3 glucan, a common PAMP of the C. albicans cell wall. 
Furthermore, we analyzed the impact of vitamin A on the interferon-β expression as well as 
well-known important receptors and regulatory factors of the interferon type I pathway in  
C. albicans infection.  
Results and discussion: 
We observed a strong immunomodulatory role of vitamin A, leading to a downregulation of 
most of the C. albicans-induced expression and secretion of the pro-inflammatory cytokines 
TNFα, IL6, IL12b. Moreover, atRA significantly downregulated the expression of Dectin-1, a 




Both RAR-dependent and RAR-independent mechanisms seem to be involved in the atRA-
mediated immune modulation.  
Furthermore, our results show an immunomodulatory impact of atRA in the key-players of the 
interferon type I pathway, well known to have a prominent role in C. albicans infections.  
Conclusion: 
Vitamin A showed an important immunomodulatory impact on the innate immune response in 
C. albicans infection. Our findings open a new direction to elucidate the role of vitamin A on 
the immune function during invasive fungal infection. It might be a new approach for further 
new antifungal substances and therapeutic strategies. 





Wissenschaftlicher Hintergrund und der aktuelle Forschungsstand:  
In den letzten Jahrzehnten ist die Anzahl der systemischen Pilzinfektionen dramatisch 
gestiegen. C. albicans repräsentiert den vierthäufigsten nachgewiesenen Erreger in 
Blutkulturen in an Sepsis erkrankten Erwachsenen. Auf Intensivstationen ist dieser Erreger 
sogar die dritthäufigste Ursache für Sepsis bei Erwachsenen und Kindern. 
In Pilzinfektionen, ist C. albicans der am meist vorkommende und nachgewiesene Erreger in 
Infektionen des Blutkreislaufes. Systemische C. albicans Infektionen sind häufig verbunden 
mit einer hohen Morbiditäts- und Mortalitätsrate.  
Vitamin A ist ein wichtiger Baustoff in der Embryogenese, in der Fortpflanzung, in der 
Zelldifferenzierung und in dem Zellwachstum sowie vielen weiteren biologischen 
Stoffwechselvorgängen. Neben diesen bedeutungsvollen Fertigkeiten wurden für Vitamin A 
und seinen nuklearen Rezeptoren (NR1B1, NR1B2, NR1B3) wichtige 
immunmodulatorischen Fähigkeiten im angeborenen und erworbenen Immunsystem 
nachgewiesen. Die Therapie mit Vitamin A und seinen Vertretern zeigte in 
Infektionskrankheiten, die durch Bakterien, Protozoen oder Viren verursacht wurden einen 
protektiven Effekt. Allerdings gibt es keine Informationen über die Wirkung von Vitamin A 
in Pilzinfektionen.  
Jedoch konnte man in einigen anderen nuklearen Rezeptoren, wie die PPARs (NR1C1, 
NR1C2 und NR1C3), GR (NR3C1), ERs (NR3A1 und NR3A2) und dem VDR (NR1I1) 
Einflüsse in der Pathogenität der Pilze nachweisen. 
Weiterhin scheint der Interferon Typ I Signalweg, vor allem die Interferon-β Antwort eine 
wichtige Rolle in der systemischen C. albicans Infektion zu spielen. Die Typ I Interferone 
sind schon lange ein wichtiger Bestandteil in der effektiven Therapie von Infektionen mit 
Bakterien und Viren. Der Einfluss von Vitamin A in diesem Signalweg ist bisher unbekannt. 
Fragestellung und Zielsetzung:  
In unserer Arbeit untersuchen wir die Funktion von all-trans Retinsäure (atRA), dem 
wichtigsten aktiven Metaboliten von Vitamin A, auf das angeboren Immunsystem gegen  
C. albicans in menschlichen Monozyten. 
Methodik:  
Menschliche Monozyten wurden mit UV-Licht inaktivierten C. albicans Hefepilzen 
behandelt. Die Expression der Zytokine TNFα, IL6, IL12b, IL10 und der Pattern-
Recognition-Rezeptoren (PRRs) Dectin-1, TLR2 und Gal-3 wurde auf transkriptioneller und
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post-translationaler Ebene mit Hilfe von Real-Time qPCR, ELISA und der 
Durchflusszytometrie untersucht. Weiterhin haben wir die Rolle von Vitamin A auf die 
spezifische Dectin-1 vermittelte Immunantwort auf transkriptioneller Ebene untersucht. 
Hierfür wurden Monozyten mit β-1.3 glucan beschichteten Beads stimuliert, einem 
spezifischen Ligand von Dectin-1 der in der Zellwand von C. albicans zu finden ist.  
Weiterhin, wurde der Effekt von Vitamin A auf die Expression von Interferon-β in der 
Infektion mit C. albicans erforscht. Es wurde der Einfluss von atRA auf wichtige Rezeptoren 
und regulierende Faktoren des Interferon Typ I Pfades analysiert. Dies sind Faktoren, deren 
wichtige Rolle in C. albicans Infektionen schon nachgewiesen wurden.  
Ergebnisse und Diskussion:  
Wir beobachteten eine starke immunmodulatorischen Fähigkeit von Vitamin A auf die 
Monozyten in der C. albicans Infektion. Weiterhin beobachteten wir eine Suppression der 
Expression und Sekretion der von C. albicans-induzierten pro-inflammatorischen Zytokinen 
TNFα, IL6, IL12b. Weiterhin konnten wir eine signifikante Herabregulierung der Dectin-1 
Expression beobachten, einem wichtigen PRR in der C. albicans Infektion, sowie auch in der 
Dectin-1 abhängigen Zytokine Produktion. RAR-abhängige sowie auch RAR-unabhängige 
Mechanismen scheinen in der atRA-vermittelten Immunmodulation eine Rolle zu spielen.  
Weiterhin zeigten unsere Ergebnisse einen immunmodulatorischen Effekt von Vitamin A auf 
die Expression von Interferon-β sowie auf die wichtigsten Faktoren des Interferon Typ I 
Signalweges.  
Schlussfolgerung: 
Vitamin A zeigte einen signifikanten einflussreichen immunmodulatorischen Effekt auf die 
Immunantwort des angeborenen Immunsystems in C. albicans Infektionen. Mit Hilfe unserer 
Ergebnisse könnten neue Wege aufgezeigt werden, um die Rolle von Vitamin A auf die 
Funktion des Immunsystems während systemischer Pilzinfektionen aufzuklären und zu 
erläutern. Weiterhin, könnten hiermit neue Angriffspunkte für innovative Therapiestrategien 
in der Behandlung von systemischen Mykosen entwickelt werden.  
 





Modulatory role of vitamin A on the Candida albicans-induced immune response in 
human monocytes 
 
1.1  CANDIDA ALBICANS 
 
1.1.1 C. albicans and its clinical importance  
Invasive fungal infections are a frequent cause of high mortality and morbidity, 
especially in immunocompromised and hospitalized adults and children 
(Brissaud et al., 2012, Gudlaugsson et al., 2003, Kao et al., 1999, Lepak & 
Andes, 2011, Steinbach, 2010).  
Clinical manifestation of C. albicans are spreading from mucosal epithelial 
infection, mostly found in healthy- and moderate immunocompromised patients, 
to disseminated infection mostly seen in critically ill patients  (Gudlaugsson et 
al., 2003, Martin et al., 2011, Xie et al., 2008). 
Among all fungi, Candida species, especially C. albicans is the most common 
nosocomial blood stream pathogen. It is capable to cause opportunistic systemic 
infections, associated with a high risk in sepsis leading to septic shock and multi-
organ failure (Arendrup, 2013, Brissaud et al., 2012, Guzman et al., 2011, Leroy 
et al., 2009, Otto et al., 2011, Xie et al., 2008) 
  
1.1.2 Epidemiology 
Over the past decades, the incidence of fungal agents is on a rise, especially 
among hospital-acquired opportunistic infections (Pfaller & Diekema, 2010, 
Tortorano et al., 2006).  
Invasive fungal infections are an increasing feared condition in critically ill 
patients in the ICU and PICU (Bajwa & Kulshrestha, 2013, Brissaud et al., 2012, 
Delaloye & Calandra, 2014, Matthaiou et al., 2015). Among critically ill 
patients, C. albicans is one of the most prevalent invasive fungal agents 
associated with a high morbidity and mortality rate (Bloos et al., 2013, Majer et 
al., 2012, Netea et al., 2006). Candideamia represents the 4th most common 
cause in hospital acquired bloodstream infections (Bajwa & Kulshrestha, 2013, 
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Lewis, 2009). Moreover, it ascended to the 3rd most common cause in 
bloodstream infections in adults in intensive care units and in health-care 
associated blood stream infection among children and neonates (Brissaud et al., 
2012, Lewis, 2009).    
Despite the availability of novel classes of antifungal agents, in patients with 
impaired immunity, nosocomial candideamia is still associated with a high 
mortality ranging from 30% to 50% in US and Europe (Castelli et al., 2014, 
Guzman et al., 2011, Tortorano et al., 2006, van de Veerdonk et al., 2010). In 
fact, Lepak et al. reported an attributable mortality rate of up to 75 % caused by 
Candida spp. (Lepak & Andes, 2011).  
Although the new antifungal agents show lower toxic side effects, early 
identification and subsequent treatment in the clinical daily life is still a great 
challenge (Badiee & Hashemizadeh, 2014, Castelli et al., 2014).  
In the last years, it has become clear that the host immune response plays a 
crucial role in the type and severity of Candida infection. If a patient appears in 
a healthy state, colonization by C. albicans and the host defence is balanced 
(Cantorna & Balish, 1990). C. albicans is a common part of the flora of the skin, 
gastrointestinal and genitourinary tract (Kumamoto, 2011). If an imbalance 
between the host defence and colonization of C. albicans in non- 
immunocompromised patient occurs, mucosal membrane infection like 
oropharyngeal or vaginal infection are quiet commonly seen. Nearly 75 % of all 
women and 70 % of the general population experience an overgrowth of Candida 
at some point in their lifetime (Mascellino, 2013, van de Veerdonk et al., 2010). 
Several factors of the host have been identified to increase the risk of invasive 
Candida infection (Achkar & Fries, 2010, Anwar et al., 2012, Brissaud et al., 
2012, Guzman et al., 2011, Muskett et al., 2011, Pallavan et al., 2014, Park, 
2005, Relloso et al., 2012, Saiman et al., 2000, Sano et al., 2014, van de 
Veerdonk et al., 2010). The most important risk factors are low immune response 
or immune suppression induced either by neutropenia for more than 10-15 days 
(Brissaud et al., 2012), chemotherapy (Mech et al., 2014, Sano et al., 2014, 
Zipfel et al., 2011), AIDS (Anwar et al., 2012, Sano et al., 2014), transplantation 
(Brissaud et al., 2012, Mech et al., 2014, Zipfel et al., 2011),  diabetes mellitus 
(Guzman et al., 2011, Pallavan et al., 2014) and others (Achkar & Fries, 2010, 
Anwar et al., 2012, Brissaud et al., 2012, Guzman et al., 2011, Muskett et al., 
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2011, Pallavan et al., 2014, Park, 2005, Relloso et al., 2012, Saiman et al., 2000, 
Sano et al., 2014, van de Veerdonk et al., 2010, Zipfel et al., 2011). In the state 
of low immune response, C. albicans turns into an opportunistic pathogen, which 
is able to translocate in the body by invading the epithelial barrier (Felk et al., 
2002). Through haematogenous spreading invasive focal infection like 
pyelonephritis, meningitis, endocarditis, pneumonia, peritonitis or moreover 
systemic distribution leading into life-threatening infections might occur 
(Pallavan et al., 2014, Saiman et al., 2000, Sano et al., 2014). Other risk factors 
like hormonal imbalance generated by the intake of estradiol, long-term 
glucocorticoid therapy or diabetes mellitus support the susceptibility to invasive 
fungal infections (Relloso et al., 2012). Furthermore, Vitamin deficiency is 
reported as another risk factor (Sano et al., 2014). Additionally, one of the main 
risks for invasive fungal infection is the period during a hospital stay (Guzman 
et al., 2011, Muskett et al., 2011).  
Hospital-acquired infections are the most common invasive fungal infections, 
especially during the stay in intensive care unit. 40% of invasive Candida 
infections occur in critical care units (Muskett et al., 2011). Indwelling catheters, 
renal replacement therapy, artificial mechanical ventilation, large surgeries, total 
parenteral nutrition, and long-term broad-spectrum antibiotic therapy are 
important risk factors of a life-threatening fungal disease (Anwar et al., 2012, 
Brissaud et al., 2012, Guzman et al., 2011, Lamagni et al., 2001, Muskett et al., 
2011, Pallavan et al., 2014, Park, 2005, Pfaller & Diekema, 2010, Relloso et al., 
2012, Saiman et al., 2000, Sano et al., 2014). Nonetheless, the number of 
invasive Candida infections has dramatically increased, not only observed in 
immune compromised patients or in critically ill patients with severe serious 
underlying disease, but rather increasingly seen in outpatient and non-hospital 
settings (Kao et al., 1999, Lamagni et al., 2001, Pfaller & Diekema, 2010).  
 
 1.1.3 C. albicans pathogenesis 
C. albicans is a yeast fungus, able to change reversibly its morphological stages 
from yeast to pseudo hyphae into budded hyphae according to its need (Jacobsen 
et al., 2012). Through the hyphal form, C. albicans is able to invade the host 
tissue and further escape out of the host cells after its internalization (Felk et al., 
2002, Filler & Sheppard, 2006, Jacobsen et al., 2012, Nobile et al., 2012, Toenjes 
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et al., 2005). Inside the human body a morphological change into the yeast form 
allows C. albicans to circulate in the blood for haematogenous dissemination 
(Brand, 2012, Nobile et al., 2012). Both yeast and hyphal cells of C. albicans are 
found in infected host tissues (Jacobsen et al., 2012, Spellberg & Edwards, 
2002). Several influential factors have been proven to induce a morphological 
change: high temperature, pH above 6.5, anaerobic environment and nutrient 
starvation (Ernst, 2000, Gow et al., 2012). Further virulence factors of C. 
albicans are its ability to form biofilms and to secret hydrolytic enzymes. 
Moreover, its broad genetic diversity within the species of around 6000 predicted 
genes and its ability to stimulate the anti-inflammatory immune response of the 
host are further important virulence factors of C. albicans (Brand, 2012, Cannom 
et al., 2002, Nobile et al., 2012, Perez-Nadales et al., 2014, Spellberg & 
Edwards, 2002). Although virulence factors and host risk factors, which enable 
an overgrowth of C. albicans have been identified in last few years, clear 
mechanism that endeavour C. albicans from a commensal to a severe fungal 
pathogen are still less clear. Although, novel antifungal agents are already 
present, the fungal broad-spectrum genetic diversity leads into recurring 
resistance. Furthermore, their toxic side effects and drug-drug interactions lead 
these agents to still restricted usage. These mentioned challenges and the late 
diagnosis by the difficulties to recognize afflicted patient tissues still upholds C. 
albicans as a remaining severely dangerous pathogen (Castelli et al., 2014, 
Perez-Nadales et al., 2014)  
 
1.1.4    Fungal recognition and host defence against C. albicans  
The first and essential path in the host immune defence is the capability of the 
host to recognize invaders by specific pattern recognition receptors (PRRs) on 
the surface or at the lysosome of several innate immune cells (Akira et al., 2006).   
 
1.1.4.1 The innate immune system in C. albicans infections  
The innate immune system plays a crucial role in the first line of defence by 
recognizing invaders, responding by nonspecific defence mechanisms and 
activation of the specific adaptive immune system (Kumar & Sharma, 2010). 
Anatomical barriers like the skin, the complement system, various immune cells 
and their secreted mediators are all part of the innate immune system (Kumar & 
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Sharma, 2010).  
PRRs are ubiquitously expressed receptors on the surface or in the endosomal 
compartment of several immune cells and assume a critical part of the innate 
immune system (Akira et al., 2006, Elinav et al., 2011, Loo & Gale, 2011). Four 
classes of PRRs have been described until now: Toll-like - (TLRs), C-type lectin 
- (CLRs), Nod-like - (NLRs) and RIG-I-like receptors (RLRs) (Akira et al., 
2006, Elinav et al., 2011, Loo & Gale, 2011). PRRs enable the recognition of 
unique pathogen associated molecular patterns (PAMPs). PAMPs are conserved 
microbial structures, which are not present in the host and share a number of 
different recognizable biochemical features that alert the organism to intruding 
pathogens (Akira et al., 2006, Bianchi, 2007). Well-known PAMPs include 
lipopolysaccharides (LPS) of gram-negative bacteria, β-glucans and mannans of 
C. albicans and different types of nucleic acids of  pathogens of bacterial, viral 
or fungal origin (Akira et al., 2006). Activated PRRs initiate an effective cellular 
response by inducing the innate and adaptive immune defence either directly 
through the secretion of pro-inflammatory cytokines, chemokines or other 
mediators, or through the activation of specific signalling pathways (Akira et al., 
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Most PRR signalling pathways in fungal infections lead to the activation of the 
NF-κB protein complex, unique regulators of the gene transcription (Hardison 
& Brown, 2012, Kawai & Akira, 2006). The NF-κB protein complex is capable 
to induce or amplify the gene expression of several genes in immune cells, 
leading to an increased production and release of specific necessary mediators 
to eliminate pathogens (Hardison & Brown, 2012, Kawai & Akira, 2006). 
Nevertheless, in recent years it has become clear, that not only one PRR but 
moreover a cross talk of several PRRs trigger a complex intercellular signalling 
cascade leading into an efficient innate and adaptive immune response (Hardison 
& Brown, 2012, Hontelez et al., 2012). 
The fungal cell wall of C. albicans comprises two layers of carbohydrates and 
proteins. These contents represent PAMPs particularly for the CLRs and TLRs 
(Hontelez et al., 2012). Activated by these PAMPs, several of these PRRs enable 
the release of pro-inflammatory chemokines and cytokines like TNFα, IL6, 
IL12b and type I IFN (Huppler et al., 2012, Kim et al., 2005, Majer et al., 2012, 
Navarathna et al., 2007, Netea et al., 2003, Romani et al., 1996, Steinshamn & 




N-and O-linked mannose polymers predominately compose the outer layer of 
the C. albicans cell wall to build up glycoproteins (Gow et al., 2012). The inner 
layer of the fungal cell wall contains the skeletal polysaccharide chitin and β-1.3 
glucan, which confer strength and cell shape, and the more flexible β-1.6 glucan 
(Gow et al., 2012).  
The most important PRR in C. albicans infection is the CLR Dectin-1. It 
recognizes β-1.3 glucan and is described as the key activator to a successful 
antifungal immune defence (Brown et al., 2002, Wheeler & Fink, 2006).  
Furthermore, human immune cells are able to recognize the different mannans 
of the outer layer of the fungal cell wall by either members of the lectin family: 
the Galectin-3 receptor (Gal3) and the mannose receptor or by the TLRs: TLR2 
and TLR4 (Gow et al., 2012). Whereas both TLRs and the mannose receptor are 
exclusively found on the surface of several immune cells, Gal-3 is found in 
different compartments of the human immune cells, in the cytoplasm, membrane 
or in the nucleus (Akira, 2009, Biondo et al., 2012, Hardison & Brown, 2012, 
Netea & Maródi, 2010, Vasta, 2012). Gal-3 is described to be an important pro-
inflammatory enhancer involved in C. albicans elimination (Akira, 2009, Biondo 
et al., 2012, Hardison & Brown, 2012, Netea & Maródi, 2010, Vasta, 2012). 
In humans, Dectin-1, encoded by the CLEC7A gene is expressed in several 
immune cells of the innate immune system like monocytes, macrophages, 
dendritic cells and neutrophils. It effectively activates the antifungal host defence 
by triggering the phagocytosis and the production of pro-inflammatory cytokines 
leading to further activation of the innate and adaptive immune system through 
signalling pathways (Brown, 2006, Esteban et al., 2011, Gow et al., 2012). It 
mainly realises its antifungal effect by the utilisation of the NF-κB protein 
complex, activated by either the Raf-1 or CARD 9 signalling pathway (Gow et 
al., 2012, Hardison & Brown, 2012, Lionakis & Netea, 2013).  
Dectin-1 is able to recognize β-1.3 glucan at the inner layer of the fungal cell 
wall in a yeast or budded stage of C. albicans, as well as after cell separation. In 
a hyphal form, the recognition of the β-1.3 glucan in C. albicans cell wall is 
blocked by chitin/mannan (Gantner et al., 2005, Gow et al., 2012, Netea et al., 
2008). Nevertheless, collaborations of certain CLRs, TLRs and enhancers like 
Gal-3 lead to an optimal antifungal response (Gow et al., 2012, Hardison & 
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Brown, 2012). Especially the crosstalk between Dectin-1, TLR2 and Gal-3 
seems to be important for an optimal antifungal host response (Esteban et al., 
2011, Jouault et al., 2006). In addition to these main surface PRRs, the 
intracellular receptors TLR7 and TLR9, located in the lysosome compartment, 
have been recently reported to play an important role in the modulation of the 
antifungal response in C. albicans infection by recognizing the fungal nucleic 
acids (Biondo et al., 2012, Biondo et al., 2011, He et al., 2013, Kasperkovitz et 
al., 2011). Like all other mentioned TLRs, they exert their effect through the 
activation of the adapter protein MyD88 leading to a modulation of the gene 
expression by the transcription factor NF-κB (Kawai & Akira, 2006, Kumagai 
& Akira, 2010, Takeuchi & Akira, 2010).  
  
1.1.4.2 The role of monocytes in the immune response against C. albicans  
Monocytes derive from the bone marrow and circulate for 3 to 5 days in the 
blood. In the blood, monocytes exert multiple functions: patrolling, initiating 
inflammation, migrating to various tissues of the host, especially in an activated 
stimulated state and exerting their repairing functions. Furthermore, monocytes 
are important for maintaining the homeostasis of the immune system 
(Geissmann et al., 2010, Italiani & Boraschi, 2014, Saeed et al., 2014, Ziegler-
Heitbrock et al., 2010). Moreover, these immune cells represent a special linkage 
between the innate and adaptive immune system not only due to their ability to 
develop into either DCs or macrophages depending on environmental cytokines 
and other mediators (Geissmann et al., 2010, Italiani & Boraschi, 2014, Serbina 
et al., 2008, Ziegler-Heitbrock et al., 2010).  In invasive C. albicans infections, 
monocytes represent one of the most important elements in the early antifungal 
defence (Kim et al., 2005, Quintin et al., 2012, Torosantucci et al., 2004, van de 
Veerdonk et al., 2009). They are equipped with several PRRs on their cell 
surface, especially the PRRs Dectin-1, TLR2 and Gal-3 (Bonfim et al., 2009, 
Liu et al., 1995). Monocytes produce an intricate pattern of cytokines and 
chemokines that enhance phagocytosis, microbicidal activity and chemotaxis, as 
well as the activation of T-cells through antigen processing and presentation 
(Geissmann et al., 2010, Kim et al., 2005, Quintin et al., 2012).  Recently, 
Quintin et al. reported a further protective capability of monocytes against a re-
infection with C. albicans, requiring the Dectin-1 PRR (Quintin et al., 2012).  
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1.2  SEPSIS: A DEREGULATION OF THE IMMUNE RESPONSE 
The adequate amount of released pro-inflammatory cytokines in the early phase 
of infection determines the further progress in either elimination of the 
pathogenic invader or development into sepsis (Navarathna et al., 2007, Netea 
et al., 2003, Romani et al., 1996, Steinshamn & Waage, 1992). A low 
concentration of cytokines in the early phase of infection leads into an ineffective 
elimination of the pathogen, whereas an excessive increase in pro-inflammatory 
mediators in local tissues might result in a cytokine storm, and lead to a massive 
systemic pro-inflammatory response, the SIRS (Comstedt et al., 2009, Netea et 
al., 2003). Sepsis, a frightening severe SIRS condition caused by a proven or 
suspected pathogen is able to lead rapidly into a life-threatening septic shock 
with cardiovascular impairment, unspecific apoptosis and lastly into MODS, a 
multiple organic dysfunction syndrome (1992, Bone, 1996, Comstedt et al., 
2009, Dellinger et al., 2013, Guzman et al., 2011, Netea et al., 2003, van der 
Zee, 2010). Candidemia is an increasing source in the development of sepsis, 
septic shock and multiple organ failure (Guzman et al., 2011, Majer et al., 2012, 
Martin et al., 2003, Spellberg & Edwards, 2002).  
 
1.2.1 Interferon Type I and IFNAR axis, an important pathway in the 
pathogenesis of systemic candidiasis 
Beside the already mentioned anti-candida host defence mechanisms, another 
pathway has recently been reported to play a relevant role to diminish invasive 
C. albicans infection: the interferon type I pathway (IFN I) (Biondo et al., 2011, 
Majer et al., 2012, Perry et al., 2005, Smeekens et al., 2013). 
The IFN I pathway is already known to play a pivotal role in the immune 
response in viral or bacterial infections (Perry et al., 2005).  
In invasive Candida infections, interferons are important mediators in the host 
defence by promoting a pro-inflammatory response of the innate immune system 
(Majer et al., 2012). Nevertheless, exaggerated activation of inflammatory 
monocytes and neutrophils by deregulated interferon levels might lead into an 
uncontrolled hyper-inflammatory response critical to cause host damage and 
sepsis-related pathology (Majer et al., 2012, Malireddi & Kanneganti, 2013).  
The interferon family contains three main classes, classified on the bases of their 
structure and their use of specific receptors, interferon type I-III  (Cho & Kelsall, 
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2014, Makela et al., 2011, Malireddi & Kanneganti, 2013, Platanias, 2005). In 
humans, the IFN I include IFN-β encoded by one gene (IFNB1), several subtypes 
of IFN-α encoded by 14 genes, and others like IFN-ω and IFN-ϵ. Both IFN-β 
and IFN-α, are reported to be important in invasive fungal infections (Malireddi 
& Kanneganti, 2013, Platanias, 2005). In systemic C. albicans infection, the 
innate immune system secretes beside several cytokines (mentioned above) 
interferon-α and interferon-β after the recognition of fungal PAMPs. For the 
release of interferon-α or interferon-β, fungal PAMPs will either be detected on 
the surface of immune cells by several PRRs like Dectin-1 or by endosomal 
located TLRs: TLR7 and TLR9 after the phagocytosis of this fungal invader 
(Bourgeois et al., 2011, Majer et al., 2012, Makela et al., 2011, Malireddi & 
Kanneganti, 2013, Platanias, 2005). Especially these TLRs, TLR7 and TLR9, 
which recognize fungal DNA/RNA, have been shown to be crucial in the 
induction of the IFN I antifungal response (Biondo et al., 2011). In invasive 
Candida infection, INF-β is reported to be among the most important cytokines 
functioning as a controller to recruit and activate inflammatory monocytes and 
neutrophils (Majer et al., 2012). The secreted IFN I binds to a common 
heterodimeric cell surface interferon α/β receptor (IFNAR), comprised by two 
chains (IFNAR1 and IFNAR2) and associated with the tyrosine kinases Jak1 and 
Tyk2 (Malireddi & Kanneganti, 2013). After inducing IFNAR1/2, associated  
JAK1/Tyk2, tyrosine kinases will recruit and activate the signal transducer and 
activator of transcription (STAT) by phosphorylation (Bourgeois et al., 2011, 
Majer et al., 2012, Makela et al., 2011, Malireddi & Kanneganti, 2013, Platanias, 
2005, Smeekens et al., 2013). Furthermore, the interferon regulatory factors 
(IRFs) and the interferon-stimulated genes (ISGs) will be activated leading into 
an IFN I-mediated paracrine/-autocrine loop (Bourgeois et al., 2011, Majer et 
al., 2012, Makela et al., 2011, Malireddi & Kanneganti, 2013, Platanias, 2005, 
Smeekens et al., 2013) 
In C. albicans infections, the homo-dimerization of STAT1 or hetero-
dimerization of STAT1, STAT 2 and the IRF1,-3,-5,-7 or IRF-9 turned out to be 
the most important parts in the regulation of the IFN I-mediated anti-C. albicans 
host response (Biondo et al., 2011, Bourgeois et al., 2011, Malireddi & 
Kanneganti, 2013, Smeekens et al., 2013).  




In a recent study, IFNAR-deficient mice seem to be protected against fungal 
sepsis related mortality by lacking to respond to IFN-β immune stimulation 
(Majer et al., 2012). Interestingly, in this study the addition of the nuclear 
receptor (NR) PPARγ seemed to modulate and deflate the hyper-inflammatory 
immune response leading into improved survival (Majer et al., 2012). 
 
1.3 NUCLEAR RECEPTORS 
 
1.3.1  Definition and general clinical importance of NRs 
NRs are a large superfamily of about 48 members of ligand- or signal-activated 
Fig. 1: IFN I pathway in monocytes challenged with C. albicans. 
 
Fig. 1: Modified Illustration by Bourgeios et al. 2011 shows the IFN I pathway in 
monocytes challenged with C. albicans. The IFN-β expression will be stimulated 
after the internalization of C. albicans and  the recognition of its fungal nucleic acids 
by the endosomal located TLR7 and TLR9.   
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transcription factors (Germain et al., 2006, Jin & Li, 2010) . They play diverse 
roles in the homeostasis of cell differentiation, development, proliferation, 
metabolism and regeneration (1999, Ali et al., 2015, Calkin & Tontonoz, 2012, 
Saijo et al., 2013). Ligands of NRs include lipophilic endocrine hormones like 
steroid hormones, thyroid hormones and vitamins like vitamin D3 or the 
retinoids, as well as fatty acids, cholesterol and several other mediators. Still not 
all have been identified so far (Aranda & Pascual, 2001). 
Increasing numbers of nuclear hormone receptors are reported to be involved in 
a large number of pathologies like cancer, cardiovascular disease, inflammation, 
reproductive abnormalities and metabolic disorders (Aranda & Pascual, 2001, 
Cheng, 2005, Committee, 1999, Ding et al., 2015, Kleiman et al., 2012a, Lavall 
et al., 2014b, Matsuda et al., 2013, Staels, 2010, Sutherland et al., 2010, 
Wetendorf & DeMayo, 2014). Accordingly, NRs have become important 
therapeutic targets to develop new strategies of treatment, already improving the 
outcome of different pathologies (1999, Aranda & Pascual, 2001, Cheng, 2005, 
Ding et al., 2015, Kleiman et al., 2012a, Lavall et al., 2014a, Luo et al., 2014, 
Matsuda et al., 2013, Staels, 2010, Sutherland et al., 2010, Wetendorf & 
DeMayo, 2014).  
 
1.3.2 Nomenclature of NRs  
The nomenclature of NRs is classified by the International Committee of 
Pharmacology, Committee on Receptor Nomenclature and Drug Classification 
(NC-IUPHAR) in a logical numbering system and receptor code like RARα 
(NR1B1) (Germain et al., 2006). In each manuscript dealing with NRs, it is 
recommended that the NRs are identified by the official name (code) at least 
once in the summary and in the introduction (Germain et al., 2006).  
Furthermore, NRs can be classified in three groups by their presence and 
knowledge of its ligands as classic receptors, adopted orphan receptors and 
orphan receptors (Germain et al., 2006, Jin & Li, 2010). Classic receptors are 
receptors regulated by already well studied endocrine ligands such as retinoic 
acids, vitamin D3, thyroid hormones and steroid hormones (Jin & Li, 2010). 
Adopted orphan receptors such as PPARs, LXRs, RXRs and others are receptors, 
for which either synthetic or natural ligands have been identified in recent years 
(Germain et al., 2006, Jin & Li, 2010, Mangelsdorf et al., 1995b). Orphan 
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receptors are a class of NRs, for which regulatory ligands still remain unknown 
or may not exist (Germain et al., 2006). 
Additionally, the members of the nuclear hormone receptor superfamily can be 
classified in several subgroups based on their interaction with the DNA: 
classified either by their different mechanisms or by their homologues structures 
(1999, Germain et al., 2006, Jin & Li, 2010, Laudet, 1997, Mangelsdorf et al., 
1995a, Olefsky, 2001).  
Earlier, four different groups of NRs were identified by Mangelsdorf et al. based 
on their characteristic mechanism (Mangelsdorf et al., 1995a). Nevertheless, one 
century later, Germain et al. classified six different groups of NRs, dividing the 
4th group of NRs, the class of orphan receptors into group IV-VI (Germain et al., 
2006).  
The type I group of NRs unifies twenty members of the thyroid hormone receptor 
like group combining the thyroid hormone receptors (TRs), retinoic acid 
receptors (RARs), peroxisome proliferator-activated receptors (PPARs), vitamin 
D-like receptor (VDR), pregnane x receptor (PXR) , liver x receptor (LXR)  as 
well as several other orphan receptors (Germain et al., 2006).  
The type II group of NRs contains the retinoid-x receptor like members: retinoid-
x receptor (RXR), the testicular receptors (TRs), the hepatocyte nuclear factor 4 
(HNF-4) as well as three orphan receptors (Aranda & Pascual, 2001, Germain et 
al., 2006).   
The type III group of NRs, the estrogen receptor-like group, comprises the 
estrogen receptors (ERs), estrogen related receptors (ERRs) and the well-known 
3-ketosteroid receptors: the mineralocorticoid receptor (MR), the glucocorticoid 
receptor (GR), the progesterone receptor (PR) and the androgen receptor (AR) 
(Germain et al., 2006).  
The type IV–VI groups of NRs comprise beside the oxysterol mediated 
Steroidogenic factor 1(SF-1), Fushi Tarazu factor 1 (FTZ-F1) several orphan 
receptors which are increasingly apparent in the human body, especially for 
medical therapy (Han et al., 2013, Kohler et al., 2008). However less is known 
so far about these six members (Aranda & Pascual, 2001).   
Furthermore, NRs can be classified  into four classes according to their ligand 
binding, DNA binding, and dimerization properties: steroid receptors, 
heterodimers, homodimeric orphan receptors, and monomeric orphan receptors 
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(Mangelsdorf et al., 1995b). Homo- and heterodimeric NRs bind with each 
partner to their specific response elements sequences on target genes (Olefsky, 
2001). According to the class of NRs, the NRs of class I-III bind specific DNA 
sequences of the target gene as homo- or hetero dimeric partners , whereas NRs 
of class IV bind specific DNA sequences as monomers  (Olefsky, 2001). 
Heterodimeric NRs mainly enter a heterodimeric partnership with the common 
retinoid x receptor (Germain et al., 2006).  Heterodimer forming partnership 
with members of the RXR-family can be classified into two groups depending 
on their functionality as heterodimers: the permissive and non-permissive RXR 
containing heterodimers (Aranda & Pascual, 2001, Pawlak et al., 2012). 
Permissive RXR-partners like PPARs and LXRs can be activated either by their 
own ligands or by RXR-agonists (Aranda & Pascual, 2001, Pawlak et al., 2012). 
Non-permissive partners like RARs, VDR and TRs cannot be activated by RXR-
agonists and require the ligands of their own to be activated (Aranda & Pascual, 
2001, Pawlak et al., 2012).  
 
1.3.3 General structure and mechanism of NRs 
All nuclear receptors are comprised by a main basic structure, composed of five 
to six domains from A to F, from the N-terminal to the C-terminal end on the 
basis of regions of conserved sequence and function (Fig. 2) (Aranda & Pascual, 
2001, Germain et al., 2006, Jin & Li, 2010). A hypervariable N-terminus (A/B-
domain) linked by a conserved C–region; the DNA-binding domain (DBD); a 
linking region called the D-domain followed by the conserved ligand-binding 
domain (LBD), the E/F-region (Jin & Li, 2010).  
The N-terminus, a hypervariable 
NH2-region also called A/B 
domain, frequently contains an 
activation function region 1 
(AF-1), capable of activating the 
gene transcription either in a 
ligand-dependent or -
independent manner (Aranda & 
Pascual, 2001, Khan & Vanden Heuvel, 2003). This A/B region and the AF-1 
region is assumed to be responsible for cell type-specific, species-specific and 
 
Fig. 2: Basic structure of NRs  
by Aranda & Pascual 2001 
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receptor-specific activities. It facilitates “promotor context-dependent 
properties” (Aranda & Pascual, 2001, Khan & Vanden Heuvel, 2003). It is the 
target of phosphorylation due to several signalling pathways, like 
phosphorylation by the cyclin-dependent kinase in the RARs or by the MAPK 
in the ERs (Aranda & Pascual, 2001, Khan & Vanden Heuvel, 2003). The AF-1 
region is variable in size and sequence, and responsible for the different 
properties of the members of the nuclear receptor family (TR vs. GR) and 
between their subtypes/ isoforms (RARα and RARβ) (Khan & Vanden Heuvel, 
2003). Beside the AF-1 region, another transcriptional activated function region 
is present in the NRs, the AF-2 region, located near the C-terminus at the LBD. 
Nevertheless, this AF-2 region is strictly ligand- dependent and conserved 
among members of the NRs (Aranda & Pascual, 2001).  The highly conserved 
DBD located in the C-region of the NR enables the NR to recognize specific 
target sequences in the promotor region, the hormone response element (HRE) 
and to bind with high affinity to the DNA (Aranda & Pascual, 2001, Germain et 
al., 2006). The promotor region is a specific region of DNA sequences that 
initiates transcription of a particular target gene. It contains the HRE where NRs 
bind highly specific to a short nucleotide sequence of a target gene (Aranda & 
Pascual, 2001, Khan & Vanden Heuvel, 2003). HRE are bipartite elements, 
composed of one or two hexameric core half-sited motifs. These nucleotide 
sequences form palindromes (Pal), direct (DR), everted (ER) or inverted repeats 
(IR) separated by a short spacer of varying length and sequence (Germain et al., 
2006, Pawlak et al., 2012). The DBD contains two zinc fingers, a COOH-
terminal extension (CTE) and three helices (Aranda & Pascual, 2001, Khan & 
Vanden Heuvel, 2003). The first zinc finger contains the proximal or P-box 
region, an α-helix that is responsible for high-affinity recognition of the core half 
site of the response element (Germain et al., 2006). The second zinc finger 
contains the distal or D-box, an α-helix which lies perpendicular to the p-box 
helix and mediates the receptor dimerization (Germain et al., 2006). The CTE 
contains the third helix and is important for monomeric DNA binding (Aranda 
& Pascual, 2001).  
The hinge region or D-region, a linking region between the DBD and the LBD 
is a less conserved structure in the NRs and allows rotation of the DBD (Aranda 
& Pascual, 2001). 
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With the help of the LBD or E/F region, the NR is able to recognize and bind 
one, or several ligands (Aranda & Pascual, 2001). Furthermore, this region 
enables the NR to mediate homo- and heterodimerization, interaction with heat-
shock proteins (HSPs), ligand-dependent transcriptional activity and in some 
cases hormone reversible transcriptional repression (Aranda & Pascual, 2001, 
Khan & Vanden Heuvel, 2003). The sequence of the LBD differs between NRs 
as not all recognize the same ligands. Each ligand binds mainly to a ligand-
binding pocket, a hydrophobic region surrounded by 10 to 13 α-helices (Aranda 
& Pascual, 2001, Khan & Vanden Heuvel, 2003). 
 
 1.3.4  General mechanism and function of NRs 
NRs are ligand or signal activated transcription factors that control transcription 
by several mechanisms, including both activation and repression activities 
(Germain et al., 2006). In a classical model, NRs are located in an inactive form 
either bound to chaperones like HSPs in the cytosol or in the nucleus until the 
lipophilic ligand enters the cellular or nuclear membrane (McEwan & Kumar, 
2015). The presence of the ligand induces a receptor-ligand interaction by 
binding to the LBD, promoting a conformational change and leading to the 
dissociation of the HSPs (McEwan & Kumar, 2015). Next the activated receptor-
ligand complex in the cytosol can translocate in the nucleus (McEwan & Kumar, 
2015). Inside the nucleus, the essential step in the NR-mediated transcriptional 
activity is the interaction with the specific DNA sequence, the HRE (Germain et 
al., 2006). NRs, bind according to their class either as homo- , heterodimers 
(class I-III) or as monomers (class IV) to the HRE (Olefsky, 2001). HREs are 
often present as two half-site motifs formed as palindromes (head to head ), 
direct repeats (DR) or inverted palindromes (IR) (tail to tail) (Laudet, 1997). 
Members of the class I NRs, the steroid receptors, mainly bind as homodimers 
to palindromic sequences composed of six base pairs (bp) arranged as inverted 
DNA repeats spaced by three bp (IR3)(Aranda & Pascual, 2001, Laudet, 1997, 
Neill Ph.D., 2006, Pawlak et al., 2012). Furthermore, several non-steroidal NRs 
can bind their HRE as homodimers, but binding to their HRE as heterodimers 
increases the efficiency of the DNA binding and their transcriptional activity 
(Aranda & Pascual, 2001). Most of these NRs form a partnership with members 
of the RXR-family (Germain et al., 2006). Heterodimers of the class II – III 
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recognize their HRE in half-core motifs mainly arranged as DRs, but they can 
also recognize IRs or ERs (Claessens & Gewirth, 2004, Pawlak et al., 2012). The 
spacing between the DR dictates the type of heterodimer recognizing it, a DR 
separated by five nucleotides (DR5) will often be recognized by RXR:RAR 
partnership whereas RXR:TR heterodimer recognize DR4 (Laudet, 1997). 
Orphan receptors bind as monomers with high affinity to the DNA, utilizing the 
CTE to sequence (Aranda & Pascual, 2001). After the NR binds to the HRE 
according to its class, the ligand- nuclear receptor complex is capable to activate 
the gene transcription by recruiting specific co-activator complexes (Aranda & 
Pascual, 2001, Saijo et al., 2013). Specific coactivator complexes include the 
histone acetyltransferase (HAT), chromatin remodelling and mediator 
complexes and general transcription machineries formed by the RNA- 
polymerase II and general transcription factors (Germain et al., 2006, Sladek, 
2011). Nevertheless, the allosteric effect of the ligand and the HRE on NRs 
seems to determine which co-activator complexes are recruited and what kind of 
activities the complex will exert (Claessens & Gewirth, 2004).  
Furthermore, NRs are also able to abrogate the transcription by the use of several 
transrepressor proteins, such as the nuclear receptor corepressor (NCoR) and the 
silencing mediator for retinoid and thyroid hormone receptors (SMRT), by 
binding to negative HREs or by the direct repression of signal transcription 
factors on the active gene expression (Aranda & Pascual, 2001, Saijo et al., 
Fig. 3:  NRs modulate the gene expression by recruiting either co-activator 
or co-repressor complexes  
 
 
Fig. 3:  The figure of Sladek, 2011 shows the NR binding as homo – or 
heterodimer to HREs, recruiting either co-activator or co-repressor complexes 
leading to the activation or repression of gene transcription. 
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2013). These capabilities offer the NRs a particular role in the modulation of 
gene expression (Aranda & Pascual, 2001, Saijo et al., 2013).  
Furthermore, NRs modulate the gene programs not only by direct binding to 
HREs but also through signal transduction cross talk like the interference with 
AP-1 or NF-κB activities (Germain et al., 2006). Transcription activity of NRs 
on modulated promotors will be regulated by a cyclic turnover of NRs (Germain 
et al., 2006). This cycle seems to correlate with proteasome-dependent 
degradation activity and chromatin remodeling activity (Germain et al., 2006). 
 
  1.3.5 NRs are modulators of the immune response in fungal infections 
NRs are well-known actors in numerous biological roles like cell growth, 
differentiation and metabolic homeostasis (Aranda & Pascual, 2001, Jin & Li, 
2010). In recent years, the focus of the effect of NRs in the immune response has 
increased (Baschant & Tuckermann, 2010, Hollm-Delgado et al., 2014a, Hollm-
Delgado et al., 2014b, Khoo et al., 2011b, Khoo et al., 2012, Mayo-Wilson et 
al., 2011, Nagy et al., 2012, Nalbandian & Kovats, 2005, Nixon et al., 2013). In 
fungal infection, several NRs have been suggested to play a crucial role in the 
outcome of invasive fungal infections: the GR, the PPARs, the ERs and the VDR 
(Gales et al., 2010, Khoo et al., 2011a, Lim et al., 2015, Lionakis & 
Kontoyiannis, 2003, Majer et al., 2012, Relloso et al., 2012). 
 
1.3.5.1 The glucocorticoid receptor (GR) in fungal infection 
Corticosteroids, especially the synthetic forms are one of the most commonly 
used drugs in inflammatory diseases, autoimmune infections and malignancies 
(Busillo & Cidlowski, 2013, Cheng et al., 2014). These lipophilic steroids, with 
cortisol as their representative member are ligands of the GR (NR3C1), secreted 
and regulated by the hypothalamic-pituitary-adrenal gland axis (Busillo & 
Cidlowski, 2013).The GR is well known for its anti-inflammatory regulatory 
capabilities like the repression of pro-inflammatory gene expression (Busillo & 
Cidlowski, 2013, Kassel & Herrlich, 2007, Kleiman et al., 2012b, Nixon et al., 
2013). A lack of these important regulators by adrenalectomy or other causes of 
irregular production in steroids are associated with a higher mortality and low 
survival rate within sepsis and septic shock (Kleiman et al., 2012a). Furthermore, 
an augmented endogenous production of corticosteroids, called the Cushing 
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syndrome or external intake of high-dose cortisol-derivate accompanied with 
increased long-term glucocorticoid level induces an impairment of immune cell 
activity (Lionakis & Kontoyiannis, 2003, Scheffel et al., 2010). These patients 
are associated with a high risk in life-threatening invasive fungal infections 
(Lionakis & Kontoyiannis, 2003, Scheffel et al., 2010). 
 
1.3.5.2 The estrogen receptors (ERs) in fungal infection 
ERs are steroid/thyroid hormone receptors, containing two subtypes: ERα 
(NR3A1) and ERβ (NR3A2), which are widely expressed in different types of 
tissues in male, female, including immune tissues and immune cells (Ascenzi et 
al., 2006, Nalbandian & Kovats, 2005, Shi et al., 2013). The best-known effector 
of the ERs is 17β-estradiol (Acconcia & Kumar, 2006, Ascenzi et al., 2006). In 
acute inflammation, estradiol reduces inflammatory mediators induced by LPS, 
restores immunological homeostasis and prevents inflammatory gene 
transcription by inhibiting NF-κB intracellular transport (Ascenzi et al., 2006, 
Choudhry et al., 2007, Nalbandian & Kovats, 2005, Relloso et al., 2012). 
Nevertheless, with high level of 17β-estradiol, fungi like C. albicans are allowed 
to flourish and increase their growth, as observed in urinary epithelial tissue 
(Relloso et al., 2012).  In humans, high level of 17β-estradiol is observed mainly 
in woman taking anti-contraceptive medication, during early pregnancy or 
during hormone replacement therapy (Relloso et al., 2012). In these women, 
Relloso et al. observed a limited effect of the host immune response leading to 
an increased susceptibility to systemic candidiasis (Relloso et al., 2012). 
 
1.3.5.3 The peroxisome proliferator-activated receptors (PPARs) in fungal 
infection 
 The PPARs are well-known modulators of the glucose, lipid and amino acid 
metabolism as well as of the immune response (Nagy et al., 2012, Rigamonti et 
al., 2008). Three known subtypes of this NR are identified so far: PPARα 
(NR1C1), PPARδ (NR1C2) and PPARγ (NR1C3) (Matsuda et al., 2013, 
Schoonjans et al., 1996). PPARα and PPARγ are efficient modulators of the 
immune response in humans, PPARγ especially in invasive fungal infections 
(Gales et al., 2010, Majer et al., 2012, Marx et al., 2004, Matsuda et al., 2013, 
Nagy et al., 2012, Rigamonti et al., 2008). PPARs are generally expressed in 
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adipose tissue, colon and immune cells like the macrophages, important cells for 
the inflammatory regulation (Coste et al., 2008, Majer et al., 2012, Rigamonti et 
al., 2008). Macrophages have multiple defence mechanism to eliminate Candida 
effectively (Coste et al., 2008). The activation of PPARγ by its ligands, such as 
the synthetic agonist pioglitazone, leads to an increase of macrophage activity. 
Furthermore, PPARγ induces the transcription of antifungal PRRs like the 
Dectin-1 receptor (Coste et al., 2008, Gales et al., 2010). 
In another study, Majer et al. observed an induction of the pro-inflammatory IFN 
I cytokine response in mouse monocytes during the challenge with invasive 
Candida infection (Majer et al., 2012). With the help of the induced IFN I 
response, monocytes were capable to diminish this fungal invader (Majer et al., 
2012). However, an overstimulation of these cytokines led to a life-threatening 
stage with poor outcome (Majer et al., 2012). The treatment with pioglitazone 
led into increased survival and restoration of immunological homeostasis (Majer 
et al., 2012).  
 
1.3.5.4 The vitamin D receptor (VDR) in fungal infection 
Vitamin D deficiency is repeatedly reported to occur in critical ill patients, adults 
as well as children (Amrein et al., 2014, McNally et al., 2012). It is associated 
with a longer hospital stay and critical outcome (Amrein et al., 2014, McNally 
et al., 2012). The VDR (NR3I1) acts by its biological active ligand vitamin D3 
(1.25(OH)2D3)  as well as by several synthetic agonists (Khoo et al., 2011a, Mora 
et al., 2008). The VDR is present in most immune cells (Khoo et al., 2011a) and 
modulates a broad range of the immune responses of the innate and adaptive 
immune system, particularly in bacterial and fungal infection (Khoo et al., 
2011a, Khoo et al., 2011b, Mora et al., 2008, Nagy et al., 2012, Youssef et al., 
2011). Khoo et al. observed a downregulation of the C. albicans-induced 
cytokine secretion in PBMCs in the presence of 1.25(OH)2D3 in vitro (Khoo et 
al., 2011a). This downregulation was mainly mediated by the inhibition of the 
expression of PRRs like Dectin-1, TLR2 and TLR4 at transcriptional and post-
translational level (Khoo et al., 2011a, Khoo et al., 2011b, Nagy et al., 2012). 
Furthermore, a recently released study by Lim et al. showed a dose- and target 
cell-dependent potential of vitamin D3 to act both as an anti- and as a pro-
inflammatory agent during fungal infections (Lim et al., 2015).  
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Of 48 members of the NRs super family, only four NRs, the GR, ERs, PPARs 
and the VDR, are reported to play a role in fungal infections. Although many 
NRs are well known for their important status in the immune response, like the 
vitamin A receptor, nothing is known about its function in fungal infection.  
 
1.4  VITAMIN A AND THE INTERACTION WITH ITS NRs: THE 
RETINOIC ACID RECEPTORS   
 
1.4.1  General importance of vitamin A 
Vitamin A and its derivatives, the retinoids, are important lipophilic mediators in 
a wide field of biological processes including cell development, cell 
differentiation, apoptosis and homeostasis (Alvarez et al., 2014, Mora et al., 
2008). Furthermore, they are important mediators in vision, reproduction, 
embryonic growth, bone metabolism, haematopoiesis, maintenance of the skin 
and the cellular health, the brain function as well as modulators of the immune 
response (Alvarez et al., 2014, Hall et al., 2011, Mora et al., 2008, O'Byrne & 
Blaner, 2013). Already in the 1920s, vitamin A was reported to be an anti-
infective vitamin (Green & Mellanby, 1928, Semba, 1999). In 1925, Wolbach & 
Howe observed an atrophy of the spleen and the thymus gland in vitamin A 
deficient (VAD) rats (Wolbach & Howe, 1925). Furthermore, from the late ´90s 
until now, VAD children, especially in developing countries, were reported to 
show a higher risk of death from common childhood illness (Glasziou & 
Mackerras, 1993, Hollm-Delgado et al., 2014b, Mayo-Wilson et al., 2011, 
Pokhrel et al., 1994, Sommer et al., 1986). Moreover, in recent years, the 
immunological function of vitamin A has been in focus of intense clinical 
research (Hall et al., 2011, Ho et al., 2005, Ouziel et al., 2013).  
 
1.4.2 Uptake, metabolism and storage of vitamin A  
Vitamin A has to be obtained through the diet, but can be stored within the body 
in relatively high doses (O'Byrne & Blaner, 2013). In humans, vitamin A is found 
either as the pro-vitamin A (the carotenoids like β-carotene), or as one of the 
preformed vitamin A metabolites (retinal, retinol, retinyl ester), and in low 
concentration as all-trans retinoic acid (atRA), the most active metabolite of 
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vitamin A (Alizadeh et al., 2014, Alvarez et al., 2014, O'Byrne & Blaner, 2013, 
Theodosiou et al., 2010).  
Preformed vitamin A is found in animal products and grains whereas highly 
pigmented vegetable products such as carrots, squash and yams mainly ensure 
the uptake of carotenoids (Alizadeh et al., 2014, Theodosiou et al., 2010). 
However, the bioavailability of retinol and carotenoids differs in humans 
(Burchum & Rosenthal, 2014). To measure the vitamin A activity, the retinol 
activity equivalents (RAE) is used as the most recent international standard, 
where vitamin A = μg retinol + (μg β-carotene equivalents/12)(Burchum & 
Rosenthal, 2014). 1 RAE equals 1μg retinol or 12 μg β-carotene (Burchum & 
Rosenthal, 2014). Nevertheless, various dietary factors like the food matrix or 
the specificity of transporters in the intestines have an effect on the 
bioavailability and bioaccessibility of carotenoids (Reboul et al., 2006, van Het 
Hof et al., 2000). In westernized countries, preformed vitamin A metabolites like 
retinol represent the main source of the vitamin A intake, in developing countries 
the main vitamin A source is covered by the uptake of carotenoids (Penniston & 
Tanumihardjo, 2006). It might be another cause of high incidence in VAD in 
developing countries.  
For optimal intestinal absorption of the fat-soluble vitamin A, co-ingestion of 
dietary fat is required to enhance the uptake of preformed vitamin A metabolites 
and carotenoids (Harrison, 2012, Reboul, 2013). In the intestine at the mucosal 
epithelial barrier of the enterocytes, retinyl ester have to be hydrolysed at the 
luminal border to yield free retinol (O'Byrne & Blaner, 2013). Free and 
unesterified retinol can be directly absorbed by the enterocytes, enabled by the 
presence of efficient specific transporters (O'Byrne & Blaner, 2013, Reboul, 
2013). Carotenoids are transported either unmodified via non-specific 
transporters or converted within the enterocytes into retinal by the BCMO1 
enzyme (O'Byrne & Blaner, 2013, Reboul, 2013). This might explain the 
difference in the efficiency of retinol absorption (range between 75 % to 100 %) 
as compared to the less efficient absorption of carotenoids (from 3 % to 90 %) 
(Haskell, 2012, Reboul, 2013).  
After the uptake within the enterocytes, all substrates will be transported to the 
hepatocytes by binding to chylomicrons (O'Byrne & Blaner, 2013).  
From the  liver, retinoids are distributed according to their need inside the body 
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(O'Byrne & Blaner, 2013). Several binding proteins stabilize and solubilize the 
lipophilic vitamin A metabolites: retinol binding proteins (RBPs), cellular retinol 
binding protein 1 (CRBP1), cellular retinoic acid binding proteins (CRABP1 and 
CRABP2) and albumin (Alizadeh et al., 2014, Hall et al., 2011). Retinol is the 
main transport form of the retinoids in the plasma, binding to the RBPs, 
circulating within the bloodstream of the body to provide the target cells with 
retinoids (Sun & Kawaguchi, 2011). Several controlling factors are existent to 
provide a constant blood concentration level of retinol including the enzymes 
that esterify retinol and hydrolyse retinol esters in the tissues (Ball, 2004, 
Penniston & Tanumihardjo, 2006). Retinol serves as a precursor of several active 
forms of the retinoids. It can be oxidized either reversibly in all-trans retinal or 
in all-trans retinoic acid (atRA) in an irreversible manner. Furthermore, retinol 
can be esterified to retinyl ester for further vitamin A storage in the stellate cells 
inside the liver (Nagy et al., 2012, O'Byrne & Blaner, 2013, Ross et al., 2011). 
Moreover, immunological tissues like spleen, thymus and lymph nodes consist 
of small amounts of retinyl ester, suggesting an important role of retinoids in 
immunological functions (Ross et al., 2011). Retinyl esters have no known 
biological activity aside from retinol storage and serving as the substrate for the 
formation of the visual chromophore 11-cis-retinal (O'Byrne & Blaner, 2013). 
All-trans retinal serves as an intermediate metabolite in the synthesis of all-trans 
retinoic acid (Nagy et al., 2012). It derives either from retinol or β-carotenes by 
alcohol dehydrogenases, short chain reductases  or β-carotene-15,15 ′-
monooxygenase (BCMO1) (O'Byrne & Blaner, 2013).  
For its biological activity, vitamin A has six known active metabolites, with atRA 
being the predominant physiological form for transcriptional regulation (Al 
Tanoury et al., 2013, O'Byrne & Blaner, 2013, Theodosiou et al., 2010). AtRA 
can either be produced inside the target cells, transferred to the nucleus by 
binding to CRABP I or CRABP II, or circulating in the plasma by binding to 
albumin (O'Byrne & Blaner, 2013). Nevertheless, because of its toxic character, 
retinol is the preferred transport form of retinoids in the blood circulation (Sun 
& Kawaguchi, 2011). Multiple factors seem to influence the generation of 
retinoic acid. So for example, atRA itself, fatty acids, TLR ligands and GM–CSF 
promote retinoic acid synthesis, whereas prostaglandin E2 inhibits its production 
(Alizadeh et al., 2014, Kedishvili, 2013). Some immune cells have been reported 
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to generate atRA from plasma-retinol for paracrine action. This paracrine activity 
is important in the modulation of the innate and adaptive immune system, 
inducing mainly an anti- but also a pro-inflammatory response, depending on the 
concentration level of atRA (Abraham & Medzhitov, 2011, Hall et al., 2011, 
Nagy et al., 2012). Since atRA is known for its toxic character and high doses of 
retinoic acid are associated with teratogenicity and other side effects, the 
concentration of atRA within the cells is usually low and tightly regulated 
(Kedishvili, 2013, O'Byrne & Blaner, 2013). Furthermore, atRA cannot be 
recycled to retinol or retinal. It has to be degraded by several members of the 
cytochrome P450 enzyme family (Kedishvili, 2013, O'Byrne & Blaner, 2013).  
 
1.4.3 Biological function of vitamin A and its NRs: the RARs  
AtRA is the main mediator of vitamin A to modulate gene expression, either 
activating or repressing it (Al Tanoury et al., 2013, O'Byrne & Blaner, 2013). 
Inside the target cells, atRA binds to the CRABP II, which mobilizes atRA to the 
nucleus. In the nucleus, atRA exerts its function by serving as an activating 
ligand of the retinoic acid receptors (RARs), which can form homodimers, but 
mainly forms heterodimers with retinoic x receptors (RXRs) (Altucci & 
Gronemeyer, 2001, Kedishvili, 2013, Osz et al., 2012). For complete activation, 
the activated RAR: RXR dimer functions as a transcription factor, binds to the 
retinoic acid response elements (RAREs) in the promotor region of target genes 
and modulates transcription of these genes (Altucci & Gronemeyer, 2001, 
Cunningham & Duester, 2015, Ross, 2011). Nevertheless, the binding capability 
of the RARs are reported to differ depending on the dimeric partner. The 
homodimer RAR: RAR is reported to bind only high affine to the target genes if 
coactivators are present (Osz et al., 2012, Walfish et al., 1997). Nevertheless, the 
common RAR: RXR dimer, binds stably and with high affinity to the target genes 
in a non-permissive manner (Perez et al., 2012, Ross et al., 2011).  
In an unliganded state, the RAR: RXR dimer associates with corepressor 
complexes such as NCoR1 or SMRT, which reside in or recruit complexes with 
HDACs activity while binding to the RAREs (Rochette-Egly & Germain, 2009). 
This association enables the complex to function in a repressive manner, for 
example by generating a condensed chromatin structure over the target promotor 
(Al Tanoury et al., 2013, Rochette-Egly & Germain, 2009, Ross et al., 2011). 
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Also other corepressors like Transducin-β-like 1 (TBL1) or other kinds of 
repressors such as Topoisomerase IIβ have been reported to interact with RAR 
target genes (Rochette-Egly & Germain, 2009). Nevertheless, the presence of 
atRA induces allosteric conformational changes in the LBD of the RAR dimer, 
leading to the dissociation of the corepressor complex (Al Tanoury et al., 2013, 
Rochette-Egly & Germain, 2009). This step provokes an intensive binding of the 
RAR dimer to the target region, uniting further coactivators and large complexes 
with enzymatic activities, such as the decompactation of the chromatin (Al 
Tanoury et al., 2013, Ross et al., 2011). The classical coactivators bind to the 
surface of the RARs by a highly conserved LxxLL motif, whereas other co-
regulators bind through other surfaces (Al Tanoury et al., 2013). Once the 
chromatin is relaxed, the multiprotein complex consisting of the mediator, the 
DNA-dependent RNA – polymerase II, general transcription factors and nuclear 
excision repair factors (NER) is recruited to the promotor region, resulting in the 
initiation of the transcription (Al Tanoury et al., 2013, Ross, 2011).  
The termination of the transcription is realised either by degradation of RARs 
through the ubiquitin-protease complex and/or by recruitment of non-
conventional coactivators with LxxLL motifs, such as RIP140 and PRAME 
which are associated to large complexes with chromatin repressing activity (Al 
Tanoury et al., 2013).  
Beside this mentioned direct, classical pathway, atRA uses other mechanisms to 
modulate the gene expression.  
It uses direct mechanisms such as direct protein-protein interactions with other 
non-related transcriptions factors to activate or suppress the gene transcription 
(Harant et al., 1996, Ho et al., 2005). For example, retinoic acid acts as a negative 
regulator of the AP-1 responsive genes by the interaction of RARs with c-Jun, a 
member of the AP-1 transcription factor complex resulting in prevention of AP-
1 binding to its response element (Harant et al., 1996, Ho et al., 2005). 
Furthermore, several indirect regulatory mechanism of retinoic acid in gene 
expression exists. For example, the induction of an intermediary (usually a 
transcription factor), which is directly responsible for the effect, like the NFκB-
complex in immunological processes, the modulation of mRNA stability and the 
interaction with NRs other than the classical RAR: RXR dimers (Bianchi et al., 
2009, Dai et al., 2004, Harant et al., 1996). Beside these mentioned modulatory 
  1. INTRODUCTION 
39 
 
effect which atRA exerts inside the nucleus, additional extra nuclear, non-
transcriptional effects of retinoic acid are existent. AtRA is capable to interfere 
rapidly and transiently through non-genomic effects (Al Tanoury et al., 2013). 
These non-genomic effects include the modulation of the MAPK or Janus 
kinase-signalling pathway by the use of phosphorylation processes or the 
modulation of other NRs like the PPARs (Al Tanoury et al., 2013). Interestingly, 
it has been shown that these retinoic acid-induced kinases cross talk with the 
transcriptional activity of RARs and other transcription factors (Al Tanoury et 
al., 2013). This interference mainly takes place through phosphorylation 
processes that influences their DNA recruitment, timings of the sequential 
recruitment of different classes of co-regulators as well as the stability of the 
phosphorylated proteins (Al Tanoury et al., 2013).  
Even RARs and RXRs are phosphoproteins (Al Tanoury et al., 2013). For 
instance, RARγ can interact in a non-phosphorylated state with vinexin-β, an 
adaptor protein which represses the RARγ-mediated transcription by inhibiting 
the binding of RARγ to the DNA and its sequestration out of chromatin (Al 
Tanoury et al., 2013). This wide range of potential mechanisms of vitamin A to 
modulate genes suggesting a wide spreading nature of vitamin A in biological 
functions (Al Tanoury et al., 2013).  
 
1.4.4  Clinical importance of vitamin A in the immune system 
The immunological function of vitamin A has been in focus of intense clinical 
research in the recent years (Hall et al., 2011, Ho et al., 2005, Ouziel et al., 2013). 
Vitamin A has been shown to reduce excessive inflammatory monocyte response 
observed in patients with acne (Dispenza et al., 2012, Ouziel et al., 2013). 
Retinoids and their synthetic isoforms are already widely used against pro-
inflammatory skin diseases and different malignancies (Alizadeh et al., 2014, 
Altucci & Gronemeyer, 2001, Dispenza et al., 2012). Furthermore, plasmatic 
vitamin A deficiency has been correlated with scores of severity and increased 
inflammatory immune response in alcoholic liver disease (ALD) patients. Ouziel 
et al. observed a decrease in the overproduction of TNF-α in LPS-stimulated 
PBMCs of ALD patients after pre-treating these immune cells with atRA in vitro 
(Ouziel et al., 2013). Furthermore, Ouziel et al. investigated the impact of 
vitamin A in vivo in VAD mice (Ouziel et al., 2013). He observed a decrease in 
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the activation of peritoneal macrophages after supplementing these mice with 
vitamin A (Ouziel et al., 2013). In infections of bacterial, protozoan and viral 
origin, treatment with vitamin A showed a protective effect (Hollm-Delgado et 
al., 2014b, Mayo-Wilson et al., 2011, Semba, 1999). Retinoic acid suppresses 
the production of several pro-inflammatory cytokines such as IL12 and 
mediators like the NO in LPS-activated macrophages (Pino-Lagos et al., 2008). 
Furthermore, Austenaa et al. showed an inhibitory effect of retinoic acid on the 
LPS-induced NF-κB activity in the human myeloblastic cell line U937 
(Austenaa et al., 2009). Moreover, vitamin A plays an immunomodulatory role 
not only in the innate immune system but also in the adaptive immune system 
(Mora et al., 2008). It has been shown to induce the overproduction of the pro-
inflammatory cytokine IL6 by activated B-cells, to exert a B-cell isotype switch 
and antibody production either in a direct or indirect effect (Pino-Lagos et al., 
2008). In T-cells, retinoic acid induces in the presence of TGF-β the conversion 
from naive T-cells into regulatory T-cells, which are important for immune 
system homeostasis and prevention of autoimmune diseases (Liu et al., 2015, 
Raverdeau & Mills, 2014). Furthermore, RA regulates the differentiation of TH 
cells (Iwata et al., 2003, Liu et al., 2015, Raverdeau & Mills, 2014). It is reported 
to promote the anti-inflammatory TH2-cell response, while inhibiting the pro-
inflammatory TH1-cell response as well as the TH17 cell induction in an 
inflammatory setting (Iwata et al., 2003, Liu et al., 2015, Raverdeau & Mills, 
2014).  
In intra-abdominal sepsis, Demetriou et al. showed a significant protective effect 
of vitamin A in adult male rats (Demetriou et al., 1984).  
Since secondary infections due to post-sepsis immunosuppression are a major 
cause of death in patients, Martire-Greco et al. investigated the effect of atRA on 
LPS-immunosuppressed mice (Martire-Greco et al., 2014). The treatment with 
atRA restored T-cell proliferation and showed an increase in CD4+- and CD8+ 
TH-cells.  
Summarizing, vitamin A seems to have an impact on several parts of the immune 
system (Al Tanoury et al., 2013, Bianchi et al., 2009, Harris et al., 2004, Liu et 
al., 2015, Pino-Lagos et al., 2008, Raverdeau & Mills, 2014, Theodosiou et al., 
2010). 
Nevertheless, in fungal infection, the effect of vitamin A is still unclear.  
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Since fungal sepsis is still on a rise, in the present work we wanted to investigate 
the impact of vitamin A in the immune response in C. albicans infections. 




1.  Vitamin A may modulate the pro-inflammatory immune response in monocytes 
upon C. albicans infection.  
2.  Vitamin A may modulate the expression levels of fungal-relevant PRRs such as 
Dectin-1 and its co-receptors, as well as the Dectin-1-dependent immune 
response in monocytes.    




1.  To investigate the effect of vitamin A on the expression pattern of the cytokines 
TNFα, IL6, IL12b and IL10 in monocytes upon stimulation with C. albicans or 
β-1.3 glucan beads. In parallel, we aim to investigate the potential modulatory 
role of atRA on the IFN I pathway. 
2. To analyse the impact of vitamin A on the expression of fungal-relevant PRRs 
such as Dectin-1 and its co-receptors TLR2 and Gal-3. 
3.  To elucidate whether the effect of vitamin A is in each case RAR-dependent by 
making use of specific agonists and antagonist of the different potential 
receptors. 
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3. MATERIALS AND METHODS  
 
3.1 MATERIALS: find attached materials used during the thesis (Tables 1-10).  
 
Every buffer and solution was prepared with distilled or double distilled water. 
The pH-value was adjusted by either hydrochloride acid or sodium hydroxide. 
 
Tab. 1:  Materials used for cultivation of C. albicans 
 
Components  Ingredients          Manufacturer 
YPD-medium Glucose 20g/ l         Carl Roth, Germany 
   Peptone 20g/ l          Carl Roth, Germany 
   Yeast extract 10g/ l         Merck, Germany 
   Millipore water up to 1 l        Merck, Germany 
   pH 5 
YPD- agar  Contents as YPD medium plus 
   Bacteriological agar 20g/ l         Sigma Aldrich, Germany 
 
Tab. 2:    Assessment of cell viability and cell count 
 
Components Manufacturer 
Trypan Blue 0.4 % 
Neubauer-counting chamber  
Invitrogen, Germany 
VWR International GmbH, Germany 
Propidium Iodide, 0.1 mg/ ml  Life Technologies, Germany 
 
Tab. 3:    Materials used for primary cell isolation 
 
 Components           Manufacturer 
Leukosep Falcon 50 ml  Greiner Bio-One GmbH, Germany 
 
MACS- Monocyte Isolation Kit II Miltenyi Biotec, Germany 
MidiMACS Separator  Miltenyi Biotec, Germany 
LS Columns Miltenyi Biotec, Germany 
DBPS pH 7  Invitrogen, Germany 
RPMI 1640 GlutaMAX TM  Invitrogen, Germany 
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Ficoll-Paque Plus  GE-Healthcare, Germany 
ACK Erythrocyte Lysing Buffer  Invitrogen, Germany 
NaCl  0.45 % , autoclaved Carl Roth, Germany 
EDTA, 0.1 M, sterile filtered Sigma Aldrich, Germany 
Fetal calf serum (FCS), heat inactivated Biochrom GmbH, Germany 
Penicillin-Streptomycin  Invitrogen, Germany 
 
Tab. 4:    Materials used for cell-culture in stimulation assay 
 Components                     Manufacturer 
Microplate 6-well  VWR International Gmb, Germany 
RPMI 1640 GlutaMAX TM   Invitrogen, Germany 
DMSO  Sigma Aldrich, Germany 
Penicillin-Streptomycin   Invitrogen, Germany 
Ethanol 99.8 %  Sigma Aldrich, Germany 
   
Tab. 5:     Materials for RNA-isolation and reverse transcription 
         5.1 Materials for RNA-isolation 
 Components           Manufacturer 
Ethanol, 99.8 % Nordbrand Nordhausen GmbH, Germany 
Nuclease free water Invitrogen, Germany 
RNeasy Mini Kit  Qiagen GmbH, Germany 
RNase-free DNase Set Qiagen GmbH, Germany 
Cell-scraper VWR International GmbH, Germany 
DNA LowBind Tubes Eppendorf AG, Germany 
Sterilfilter 3.8 μm/ cm2 Carl Roth, Germany 
Filtertips, ep Dualfilter T.I.P.S. Eppendorf AG, Germany 
 
         5.2 Material for reverse transcription from RNA into cDNA  
 Components           Manufacturer    
 High Capacity cDNA Reverse Transcription Kit       Applied Biosystems, UK 
Nuclease free water     Invitrogen, Germany 
Tris-EDTA (TE) pH 7.4; 0.5 x     FLUKA, Germany 
 S1000TM Thermal cycler          BioRad, UK 
 CAS Robotics 1200           Qiagen, Germany 
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DNA LowBind Tubes     Eppendorf AG, Germany 
Filtertips, wide bore     Quiagen, Germany 
CAS Robotics 1200      Qiagen, Germany 
 
Tab. 6:    Materials for semi-quantitative PCR and gel electrophoresis 
 
 Components                         Manufacturer 
PCR dNTP Mix Promega GmbH, Germany 
Agarose, LE analytical grade Promega GmbH, Germany 
Ethidium bromide (10 mg/ ml) Sigma Aldrich, Germany 
Quick Load 100bp DNA Ladder 50 μg/ ml New England Biolabs GmbH, Germany 
S1000TM Thermal cycler BioRad, UK 
  
Components                              Ingredients 
1x TBE-Buffer 89 mM TRIS  
89 mM Boric acid 
1 mM EDTA 
pH 8 
1.7 % Agarose gel 1.7 % Agarose LE analytical grade  
2.5 ug/ 100 ml ethidium bromide 
 
Tab. 7: Materials for real-time quantitative PCR (RT-qPCR) 
 
         7.1  Components for RT-qPCR 
 
Components                  Manufacturer 
Nuclease free water Invitrogen, Germany 
Tris-EDTA (TE) pH 7.4; 0.5 x FLUKA, Germany 
RNeasy Mini Kit  Qiagen GmbH, Germany 
RNase-free DNase Set Qiagen GmbH, Germany 
Cell-scraper VWR International GmbH, Germany 
SensiMix SYBR No-ROX Kit Bioline, Germany 
DNA LowBind Tubes Eppendorf AG, Germany 
Sterilfilter 3.8 μm/ cm2 Carl Roth, Germany 
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Filtertips, ep Dualfilter T.I.P.S. Eppendorf AG, Germany 
Filtertips, wide bore Qiagen, Germany 
CAS Robotics 1200   Qiagen, Germany 
 
7.2 Primer – of genes used in this study 
 
Humane Gene Symbol 
Peptidylpropyl Isomerase B PPIB 
Hypoxanthine Phosphoribosyltransferase 1 HPRT1 
Glyceraldehyd-3 Phosphat Dehydrogenase GAPDH 
Tumor necrosis factor alpha TNFα 
Interleukin 6 Il6 
Interleukin 12 subunit beta IL12b 
Interferon beta 1 IFNβ1 
Dectin-1 Dectin-1 
Galectin 3 Gal-3 
Toll-like receptor 2 TLR2 
Toll-like receptor 4 TLR4 
Toll-like receptor 7 TLR7 
Toll-like receptor 9 TLR9 
Retinoid x receptor alpha RXRA 
Retinoid x receptor beta RXRB 
Retinoid x receptor gamma RXRG 
Retinoic acid receptor alpha RARA 
Retinoic acid receptor beta RARB 
Retinoic acid receptor gamma RARG 
Suppressor of cytokine signalling 1 SOCS1 
Suppressor of cytokine signalling 3 SOCS3 
CD14 molecule CD14 
Mitogen-activated protein kinase phosphatase 1 MKP1 
Interferon receptor 1 IFNAR 
interferon regulatory factor 1 IRF1 
interferon regulatory factor 3 IRF3 
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interferon regulatory factor 5 IRF5 
interferon regulatory factor 7 IRF7 
interferon regulatory factor 9 IRF9 
Signal transducer and activator of transcription 1 STAT1 
Signal transducer and activator of transcription 2 STAT2 
For sequence of forward and reverse primer pair of indicated target genes and expected size of 
the PCR product see Figure 4. 
 
Tab.  8: Cell media 
 
 8.1 Medium for monocyte isolation 
 
Components   Manufacturer      
DBPS Invitrogen, Germany    
EDTA, sterile filtered, 2 mM Invitrogen, Germany 
FCS, 0.5 %, heat- inactivated  Invitrogen, Germany 
  
        8.2      Medium for cell culture 
 
 
Primary cell stimulation assay  
Components Manufacturer 
RPMI 1640 GlutaMAX TM Invitrogen, Germany 
Penicillin-Streptomycin, 1 %  Invitrogen, Germany 
  
THP-1 cell culture medium  
Components Manufacturer 
RPMI 1640 GlutaMAX TM Invitrogen, Germany 
Penicillin-Streptomycin, 1 %  Invitrogen, Germany 
FCS, 10 %, heat- inactivated  Biochrom GmbH, Germany 
 
THP-1 cell stimulation assay  
Components Manufacturer 
RPMI 1640 GlutaMAX TM Invitrogen, Germany 
Penicillin-Streptomycin, 1 %  Invitrogen, Germany 




        8.3  Medium for flow cytometry-analysis 
Buffer for flow cytometry  
Components                Manufacturer    
DBPS pH 7,                      Invitrogen, Germany 
- supplemented with 2 % FCS               Biochrom GmbH, Germany 
 
Tab. 9:  Antibodies and synthetic agonists/ antagonists for stimulation assay 
         9.1  Antibodies for flow cytometry    
Human Dectin1/ CLEC7A Ingredients    Manufacturer 
Primary antibody  Monoclonal-mouse-anti-human R&D Systems, Germany 
Anti-Dectin1  
Clone 259931, (MAB1859)    
Working concentration: 1 μg/ 2 μl     
Secondary antibody  Goat-anti-mouse IgG,   BD, Germany 
APC labelled 
Working concentration: 1 μg/ 2 μl  
Isotype Control  Mouse Isotype IgG2b K eBMG2b eBioscience, Germany 
 
Human TLR2  Ingredients    Manufacturer  
Primary antibody  Monoclonal mouse-anti-human Abcam, US   
Anti-TLR2, FITC conjugated  
Clone T2.5, (ab59711) 
Working concentration: 0.2 μg/ 2 μl   
Isotype Control  Mouse IgG1 K Isotype Control  eBioscience, Germany 
    FITC conjugated  
Clone: P3.6.2.8.1 
    Working concentration: 1 μg/ 2 μl  
 
        9.2. Synthetic agonists/ antagonists 
        9.2.1 TLR-agonists for the PBMC co-fungal stimulation assay  
   
TLR- agonists  Ingredients    Manufacturer 
TLR7-agonist   Imiquimod - Imidazoquinoline Biomol GmbH, Germany 
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Amine analogue to guanosine  
Synthetic human TLR7-agonist 
Working concentration: 5 μg/ ml  
Diluted in DMSO 
TLR9-agonist   CpG Type A–Oligonucleotide InvivoGene Biotech, China 
Type A (ODN2336)  
Synthetic human TLR9-agonist 
Working concentration: 10 μg/ ml  
Diluted in water 
 
        9.2.2 Retinoic acid receptor (RAR) stimulation assay 
Retinoic acid receptor-agonists     Manufacturer 
RARα-agonist  BMS753    Tocris Bioscience, UK 
    Working concentration: 1 μM 
RARγ-agonist   BMS961    Tocris Bioscience, UK 
    Working concentration: 1 μM 
 
Retinoic acid receptor-antagonists     Manufacturer 
RARα-antagonist   BMS195614    Tocris Bioscience, UK 
    Working concentration: 1 μM 
RARγ-antagonist  MM11253     Tocris Bioscience, UK 
    Working concentration: 1μM 
 
Tab. 10:  Materials for ELISA  
Chemokine ELISA-Kit   Manufacturer  
TNFα  human TNFα ELISA-Kit Thermo Scientific Pierce Biotechnology, US  
IL6  human IL6 ELISA-Kit eBioscience, Germany 
IL12b  human ELISA IL12b  Hölzel Diagnostika GmbH, Germany 
IL10   human IL10 ELISA-Kit eBioscience, Germany 
IFNβ  human IFN-β ELISA-Kit  Thermo Scientific Pierce Biotechnology, US 




Fig. 4: Sequence of forward and reverse primer pair of indicated target genes and expected size 






Humane Gene Symbol Forward Primer Reverse Primer 
Size 
(bp) 
Peptidylpropyl isomerase B PPIB ATGTAGGCCGGGTGATCTTT TGAAGTTCTCATCGGGGAAG 219 
Hypoxanthine 
Phosphoribosyltransferase 1 HPRT1 GACCAGTCAACAGGGGACAT AACACTTCGTGGGGTCCTTTTC 195 
Glyceraldehyd-3 phosphat GAPDH ATGACCCCTTCATTGACCTC GCATCGCCCCACTTGATTTT  169 
Dehydrogenase     
Tumor necrosis factor alpha TNFα TTCTCCTTCCTGATCGTGGC ACTCGGGGTTCGAGAAGATG 150 
Interleukin 6 Il6 GAGGAGACTTGCCTGGTGAA TGGGTGAGGGGTGGTTATTG 186 
Interleukin 12, subunit beta IL12b ACAACATCGGTTTCAGGGCCA GGTCCAAGGTCCAGGTGATA 266 
Interferon beta 1 IFN-β TGCTCTCCTGTTGTGCTTCT CCACAGGAGCTTCTGACACT 103 
Dectin-1 Dectin-1 ACACTTCGACTCTCAAAGCA TACAGCAATGAGGCGCCAA 91 
Galectin 3 Gal-3 CCCATCTTCTGGACAGCCAA CTTCACCGTGCCCAGAATTG 151 
Toll-like receptor 2 TLR2 TGCATTCCCAAGACACTGGA AGGGAGGCATCTGGTAGAGT 131 
Toll-like receptor 4 TLR4 CAACCTCCCCTTCTCAACCA CTGGATGGGGTTTCCTGTCA 196 
Toll-like receptor 7 TLR7 ATCTTGGCACCTCTCATGCT ACCATCTAGCCCCAAGGAGT 158 
Toll-like receptor 9 TLR9 GAAGGGACCTCGAGTGTGAA CTCACAGGGTAGGAAGGCAG 196 
Retinoid x receptor alpha RXRA GCGCCATCGTCCTCTTTAAC TGCTCTGGGTACTTGTGCTT 121 
Retinoid x receptor beta RXRB TACTCTTGCCGGGACAACAA GCCCTGGTCACTCTTCTGTT 240 
Retinoid x receptor gamma RXRG TGCAGATGGACAAGTCGGAA TTCAAGCCAATGGAACGCAG 214 
Retinoic acid receptor alpha RARA CCACATGTTCCCCAAGATGC GCCCTGTGAGTTCTCCAACA 145 
Retinoic acid receptor beta RARB TCGTCTGCCAGGACAAATCA TGGGCATCGATTCCTGGTGA 158 
Retinoic acid receptor gamma RARG CAAGGTCAGCAAAGCCCATC ACTTGGTAGCCAGCTCAGTG 137 
Suppressor of cytokine  SOCS1 TCCCCTTCCAGATTTGACCG GGAGGGTACCCACATGGTT 103 
Signalling 1 
Suppressor of cytokine  SOCS3 GAGACTTCGATTCGGGACCA GGAAACTTGCTGTGGGTGAC 124 
Signalling 3     
CD14 molecule CD14 GCAGCCGAAGAGTTCACAAG ATCGTCCAGCTCACAAGGTT 206 
Mitogen-activated protein  MKP1 CCTTTCTGTACCTGGGCAGT GCAGTGGACAAACACCCTTC 239 
Kinase phosphatase 1     
Interferon receptor 1 IFNAR CTCCGCGTACAAGCATCTGA AGGCGTGTTTCCAGACTGTT 168 
Interferon regulatory factor 1 IRF1 AACATGCCCATCACTCGGAT TGGGATCTGGCTCCTTTTCC 226 
Interferon regulatory factor 3 IRF3 CTGCCAACCTGGAAGAGGAA TGGGAAAAGTCCCCAACTCC 140 
Interferon regulatory factor 5 IRF5 AGTACCCAGGGCTTCAATGG AGTCCCGGCTCTTGTTAAGG 213 
Interferon regulatory factor 7 IRF7 ACTGTGACACCCCCATCTTC TCGTCATAGAGGCTGTTGGC 277 
Interferon regulatory factor 9 IRF9 ATAAGGAGGGGGACACAGGA ACTTTCTGAGTCCCTGGCTG 181 
Signal transducer and activator STAT1 ACGCTGCCAATGATGTTTCA ATCTCTGGGCGTTTTCCAGA 231 
Of transcription 1     
Signal transducer and activator STAT2 TCACAGAGTTGCTACAGCGT TTGCCTTCCTGGAGTCTCAC 151 
Of transcription 2     
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3.2  METHODS 
 
3.2.1 C. albicans  
For our study, the virulent wild-type strain SC5314 of C. albicans was used, kindly 
provided by Fungal Septomics Jena, Germany, stored at -80 °C (Gillum et al., 1984).  
Culture media: C. albicans was cultivated in YPD-agar plates and YPD-medium for 
optimal growth of the fungal yeasts. Both media were prepared as described in table 1 
and autoclaved before use. YPD-agar plates were stored at 4 °C, the liquid YPD- 
medium at room temperature.  
Re-cultivation of C. albicans yeasts: For re-cultivation of C. albicans, the frozen fungus 
was stored in dry ice to protect from thawing. In sterile conditions, the fungus was 
spread over a YPD-agar plate by using a sterile inoculating loop to obtain single isolated 
colonies. The inoculated agar was incubated for 24 hours at a controlled temperature of 
30 °C and 0.04 % CO2 according to previous studies (Carlisle et al., 2009, Mayer et al., 
2012, Wang, 2009). 
C. albicans isolation: Overnight fungal yeast culture were grown in YPD-medium at 
aerobe conditions at 0.05 % CO2, 30 °C and 210 rpm in the incubator shaker series 126 
(New Brunswick Scientific) to multiply itself in numbers (Mayer et al., 2012).  
Immediately before stimulation of monocytes with C. albicans, the C. albicans yeast 
culture was washed three times and re-suspended in DPBS at a final concentration of 
108 yeast/ ml.  To avoid overbalanced growth of C. albicans regarding to our preliminary 
results and decrease of monocyte survival due to hyphal formation of living C. albicans 
we next inactivated the fungal yeasts. The UV-inactivation was performed in a UVC 
500 – Crosslinker (Amersham,UK) using two doses of 100 mJ/ cm2 immediately before 
stimulation (Esteban et al., 2011). Due to preliminary alteration in dosage in a survival 
curve of C. albicans, the dosage of UV-inactivation could be minimized to two times of 
100 mJ/ cm2 at a concentration of 1 * 108 yeasts/ ml DPBS. The morphological shape 
did not alter.  
Counting and observation of viability was performed by tryphan blue staining and 
microscopic observation (Primovert by Zeiss, Germany).  
 
3.2.2 Monocyte and PBMC isolation  
Human monocytes were isolated from buffy coats of healthy male volunteers kindly 
provided by Dr. Dagmar Barz of the Institute of Transfusion Medicine at Jena University 
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Hospital, Germany. Peripheral blood mononuclear cells (PBMCs) were isolated by 
density gradient centrifugation according to manufacturer’s instructions (Ferrante & 
Thong, 1980). Primarily, buffy coat diluted 1:4 with DBPS (Invitrogen, Germany) was 
layered on an equal volume of Ficoll hypaque Plus solution (GE Healthcare , Germany) 
and centrifuged in 50 ml sterile Leukosep tubes with porous barrier (Greiner-Bio-One 
GmbH, Germany) at 800 g for 15 min without acceleration or brake (Ferrante & Thong, 
1980). After centrifugation, a proper density gradient was observed as follows: a serum 
phase, a clear white PBMC band, and a red sediment, consisting mainly of erythrocytes, 
and granulocytes (Fig. 5). 
The PBMC-layer was collected in 50 ml falcon tubes by sterile pasteur pipettes and 
washed with equal amount of sterile, 4 °C cold, 0.45 % NaCl. The next step was 
performed to clear away remaining erythrocytes by the use of a hypotonic buffer (ACK 
Erythrocyte Lysing Buffer, Invitrogen, Germany) according to manufacturer´s 
instruction. After a washing step with DPBS the reddish cell pellet turned white. These 
last two steps were repeated if necessary. 
Two more washing steps with DPBS were included to sluice remaining thrombocytes. 
Then, PBMCs were used either directly for further experiments, adjusted to a 
Fig. 5: PBMC-isolation from buffy coat before and after density gradient centrifugation 
 
 
Fig. 5: The figure shows PBMC-isolation before (left) and after (right) density gradient 
centrifugation. PBMC-isolation was enabled by 1:4 DPBS dilution and further Fiqoll 
hypaque Plus supply.  
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concentration of 5 * 106 cells/ ml, or used for monocyte isolation. 
Untouched monocytes were isolated with the help of a MACS system, which couples 
negative labelling using biotin-conjugated antibodies with magnetic sorting using anti-
biotin beads. Consequently, highly enriched CD14+ unlabelled monocytes were 
collected. The purity of the obtained monocytes was higher than 92 % assessed by 
CD14+ labelling and flow cytometry analysis (Fig. 6). Viability of PBMCs and isolated 
monocytes was > 95 %, as proven by microscopic observation in a Neubauer-










3.2.2.1 Monocyte stimulation assay 
In the monocyte stimulation assay, monocytes are challenged with UV-inactivated  
C. albicans yeast in the presence or absence of 1 μM atRA to investigate the impact of 
vitamin A at transcriptional and post-translational level of the C. albicans-induced 
immune response. After monocyte isolation, monocytes were dispersed at 4 * 106 cells/ 
ml RPMI GlutaMaxTM medium (Invitrogen, UK) containing 1 % Penicillin/ 
Fig. 6: CD14+ monocytes after magnetic separation from PBMCs verified by flow 
cytometry 
 
Fig. 6: Verification of the purity in monocyte samples after magnetic separation of PBMCs 
by CD14- stained cells (FITC labelled). Figure shows a flow cytometry plot of monocytes 
with high purity of CD14+ cells (>95%) after magnetic separation of PBMCs. 
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Streptomycin (Invitrogen, UK) in 2 ml/ well in 6 well plates (VWR International, 
Germany). Cells were allowed to equilibrate at 37 °C, 5 % CO2 for 1 hour in the 
incubator (Galaxy 170S, New Brunswick, Eppendorf Company). Then, cells were pre-
stimulated for 30 minutes with either 1 μM atRA or specific RARα- or RARγ–agonists/ 
-antagonists, followed by the addition of freshly prepared inactivated C. albicans yeast 
at a monocyte–fungus ratio of 1:1. Additionally we used unstimulated monocytes for 
internal control as well as one control of inactivated C. albicans and one of live C. 
albicans yeast at the same ratio. To assess the impact of vitamin A on the specific  
Dectin-1 signalling pathway in monocytes, we used a Dectin-1 agonist monocyte ratio 
of 5: 1 involving β-1.3 glucan coated beads as specific ligands of the Dectin-1 receptor. 
In all experiments we used an internal unstained control with 3 μl of 99.8 % ethanol, 
sterile filtered. Monocytes were incubated for 5 hours and 16 hours at 37 °C and 5 % 
CO2. Viability of the cells was above 90 % at both times junctures, assessed by trypan-
blue staining. After 5 hours and 16 hours stimulation, culture supernatants were frozen 
at -80 °C for further ELISA-analysis. Monocytes were harvested for subsequent RNA- 
isolation. Similar stimulation procedure was used for all experiments involving flow 
cytometry measurements, although in this case only 1.5 million monocytes were used 
and the stimulation periods were 12 hours, 18 hours and 24 hours. 
 
3.2.2.2 PBMC stimulation assay 
After isolation, PBMCs were apportioned at a concentration of 5 * 106 cells/ ml in RPMI 
GlutaMax medium (Invitrogen, UK) supplemented with 1 % Penicillin/ Streptomycin 
(Invitrogen, UK) in an amount of 2 ml/ well in 6 well plates (VWR International, 
Germany) for RNA-Extraction. Cells were allowed to equilibrate for 1 hour in the 
incubator (Galaxy 170S, New Brunswick, Eppendorf Company) at 37 °C, 5 % CO2. In 
the next step, cells were pre-stimulated for 1 hour either with a specific TLR7- or TLR9-
agonist alone or in combination with 1 μM atRA. The TLR9-agonist CpG, Type A was 
used by an amount of 10 μg/ ml diluted in sterile filtered water. The TLR7-agonist 
Imiquimod was only available diluted in DMSO, used with a concentration of 5 μg/ ml. 
After 1 hours of stimulation just freshly prepared UV-inactivated C. albicans yeast at a 
monocyte–fungus ratio of 1:1 was added as well as one control of inactivated and one 
control of live C. albicans yeast at the same ratio.  
In all experiments an internal unstained control with 3 μl of 99.8 % ethanol, sterile 
filtered or with 3 μl of DMSO for Imiquimod was included. PBMCs were incubated for 
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5 hours at 37 °C and 5 % CO2.  The viability of the cells was above 95 % proven by 
trypan-blue staining. After 5 hours of stimulation, PBMCs were harvested for further 
RNA-analyses.  
 
3.2.3 Preparation of the all-trans retinoic acid  
All-trans retinoic acid (atRA), the natural agonist of the retinoic acid receptors (RARs) 
was used at a concentration of 1 μM based on previous studies and preliminary results 
(Cho et al., 2011, Li et al., 2003, Liu et al., 2000). The provided lyophilic form (Sigma 
Aldrich, Germany) of atRA was dissolved in 99.8 % ethanol and sterile filtered. Several 
aliquots of 10 mM atRA were stored at -20 °C under dark conditions for not more than 
3 months. Due to its high sensitivity to light, heat and air, a new aliquot was taken for 
each experiment. Immediately, before the stimulation assay, a working concentration of 
1 mM atRA was prepared.  
 
3.2.4 Preparation of RAR- agonists/ -antagonists 
The selective RARγ- agonist, -antagonist as well as the selective RARα-agonist and -
antagonist (Table 9.2.2) were dissolved in 99.8 % ethanol, sterile filtered and used at a 
concentration of 1 μM.  
 
3.2.5 Preparation of β-1.3 glucan beads 
β-1.3 glucan beads kindly provided by Massachusetts General Hospital, USA were 
prepared as previously described (Tam et al., 2012). Before the use of the received  
β-1.3 glucan beads in the monocyte stimulation model, we wanted to verify the purity 
of the β-1.3 glucan beads. Therefore, we incubated HEK 293 cells with the beads and 
analysed for any changes at transcriptional level similar to the induction by LPS. 
No contamination could be found.  
 
3.2.6 Preparation of TLR-agonists 
All TLR-agonists (Table 9.2.1) were present in lyophilic form. Immediately before 
stimulation, the TLR9-agonist CpG Type A was dissolved in water, whereas Imiquimod 
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3.2.7 RT-PCR and semi-quantitative PCR 
 
3.2.7.1 RNA-Isolation 
To analyse the gene expression of the target genes after 5 hours and 16 hours of 
stimulation, total RNA was isolated from 8 * 106 monocytes or 10 * 106 PBMCs / 
stimulated population by RNeasy mini kit (Qiagen, Germany). An additional step of 
RNA-isolation by the use of DNAse I was included to prevent impurity with genomic 
DNA. First of all, the culture medium was transferred by pipets into RNase free DNA 
low bind collection tubes and centrifuged at 1000 g for 5 min. Centrifuged supernatants 
were transferred into a new column leaving a cell pellet on the bottom. Supernatants 
were stored immediately at -20 °C for further post-translational analyses.  
Meanwhile, 600 μl RLT-Lysis buffer was added into each well, scrapped carefully to 
obtain RNA of leftover monocytes. This RLT buffer cell-mixture was added to the 
equivalent cell pellet compatible to the stimulation, homogenized thoroughly.   
For the next isolation steps, the RNA needs to bind to a silica membrane in RNeasy mini 
spin columns, followed by several washing steps to distinguish all contaminants. 
Therefore, an equal amount of 70 % of ethanol was added to the RLT buffer cell-mixture 
and homogenized thoroughly again, before adding to the spin column. 
Next, a centrifugation step of 30 seconds was included. Then, collection columns were 
changed to distinguish remaining guanidine. Guanidine is capable to interfere and to 
inhibit the activity of the polymerase enzyme. Further purification of the RNA was 
realized by the use of several different wash buffers in accordance to manufacturer´s 
instruction. Between each washing step columns were centrifuged at 9000 g. 
Furthermore, a DNAse I incubation step was included to prevent contamination with 
genomic DNA, followed again by a centrifugation of 9000 g. In the last step of the RNA- 
isolation, 40 μl of purified mRNA was collected in DNA low bind columns, immediately 
stored at -20 °C for 2 days, and further stored at -80 °C. To protect the RNA, nuclease-
free tubes were used in all experiments and reactions handling with RNA. 
 
3.2.7.2 Quantification of purified mRNA 
The NanoDrop D-1000 Spectrometer (Thermo-Fisher Scientific, Germany) was used to 
obtain the amount and quality of the isolated RNA, using 2 ul RNA/ sample (Nolan et 
al., 2006). After examination, the RNA was stored at – 80 °C.  
Nucleotides, RNA, ssDNA, and dsDNA, all absorb at a wavelength of 260 nm. Phenolic 
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compounds and other contaminants such as guanidine isothiocyanate absorb at ~230 
nm, whereas peptides and proteins at ~280 nm, concluding that contaminated RNA is 
mainly seen in wavelengths of 260 nm as well as 230 nm. The ratio of 260/ 280 in pure 
RNA averages between 1.8-2.0, whereas the ratio of 260/ 230 indicates pure nucleic 
acid at ~2 or above (Chomczynski & Sacchi, 2006, Fleige & Pfaffl, 2006). 
 
3.2.7.3 Reverse transcription  
For Real- Time PCR analysis, 1.5 μg of mRNA were reverse transcribed into single 
stranded complementary DNA (cDNA) using the High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, UK) following manufacturer´s instruction 
(Table 5.2) (Wang et al., 2012). The reverse transcription polymerase chain reaction 
allows the qualitative and quantitative assessment of gene expression by creating cDNA. 
The CAS Robotics 1200 (Qiagen, Germany) pipetted the reaction samples. Its six station 
channel and liquid level sensor assures reliability and accuracy. Reverse transcription 
was achieved on the S1000TM Thermal cycler (BioRad, UK) in a reaction volume of 30 
μl. Following thermal conditions were used: initially 10 min at 25 °C for annealing of 
the random primer at the RNA, followed by extension of the complementary strand for 
120 min at 37 °C and finalized by 5 min at 85 °C to inactivate the reverse transcriptase. 
To protect the new synthesized cDNA from DNases, the cDNA was resuspended in 200 
µl 0.5 % TE Buffer pH 7.4.  
 
3.2.7.4 Primer design  
For real-time qPCR analysis, specific primer of each target gene were designed based 
on previous studies (Apte & Daniel, 2009, Burpo, 2001, Chomczynski, 1993, Fleige & 
Pfaffl, 2006)  as well as with the help of more than three online tools (Birney et al., 
2004, Flicek et al., 2012, Pruitt et al., 2009, Zuker, 2003): the “Ensembl Genome” 
browser for sequence annotation, “Primer Blast” provided by the National Center for 
Biotechnology Information (NCBI) for primer design and the “Mfold Web Sever” for 
analysing possible secondary structures.  
First, with the help of the “Ensembl Genome” browser the right target sequence for the 
primer design was chosen, taking into account the different splice variants of each gene. 
The “Ensembl Genome” browser is supported by several institutes: the European 
Bioinformatics Institute (EBI), the European Molecular Biology Laboratory (EMBL), 
the Wellcome Trust Sanger Institute (WTSI) and the Wellcome Trust Genome Campus 




Next, the online “Primer-BLAST” tool was used to design primers of a target region of 
each gene of interest (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). For the 
calculation of the annealing temperature, thermodynamic calculations of Santa Lucia 
1998 were used (SantaLucia, 1998).  
To prove the efficacy of the designed primer pairs by in-silico prediction of possible 
secondary structures in the amplicon, their sequence was analysed in a FASTA-format 
using the “mfold” algorithm at “The mfold Web” server provided by the RNA Institute 
College of Arts and Sciences in US (http://mfold.rit.albany.edu/?q=mfold) (Zuker, 
2003). Primer optimization strategies were performed based on previous studies (Apte 
& Daniel, 2009, Bustin et al., 2005, Fleige & Pfaffl, 2006, Pfaffl, 2001, Wang & Seed, 
2003). The sequences and the estimated size of all primers used to amplify the genes of 
interest are listed in Figure 4.   
 
3.2.7.5 Semi-quantitative PCR  
To identify the expression of the gene of interests in the target cells, PCR was performed, 
followed by electrophoresis.  
Before the newly designed primer could be used for further PCR investigations, the 
primer had to be proven to recognize and bind only the target gene of interest and 
furthermore to amplify the correct template. Therefore, evaluation of the expected 
template and amplified products in expected size was performed by semi-quantitative 
PCR, proven and visualized by gel electrophoresis. For better accuracy the melting 
temperature (Tm) might had to be optimized or the primer had been re-designed until 
accurate specific primer templates were proven. 
PCR is a method developed by Kary Mullis in the 1980s (Mullis et al., 1986) and 
optimized in last years. PCR was done according to manufacturer´s instruction (Table 
6) and previous studies (Lorenz, 2012). cDNA of cells, known to express the gene of 
interest were amplified by PCR reaction in the S1000TM Thermal cycler (BioRad, UK) 
in a 20 μl reaction volume containing 0.2 μM/ primer (forward/ reverse), 200 μM dNTPs 
(PROMEGA GmbH, Germany), 2.5 μl Loading Dye (5-Prime GmbH, Germany) and 
0.125 μl Perfect Taq Plus polymerase (5-Prime GmbH, Germany). Thermal condition 
included an initial step to activate the Taq polymerase at 95 °C for 3 min, followed by 
35 cycles of 3 steps: 30 s at 94 °C (denaturation), 30 s at 60 °C (annealing temperature 
varied for certain amplicons depending on the primer melting temperature) and 30 s at 
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72 °C (complementary elongation of the templates by the polymerase). Finally, an 
extension or elongation step for 10 min at 72 °C was performed to ensure that no single-
stranded DNA is remaining.   
 
3.2.7.6 Gel electrophoresis 
To detect and identify the amplified PCR products of the genes of interest, DNA gel 
electrophoresis was realized (Mavre et al., 2010). Gel electrophoresis is a common 
technique to detect and identify DNA fragments based on the size (Mavre et al., 2010). 
Agarose was dissolved in TBE-buffer (Tris-Borate-EDTA-buffer) to a concentration of 
1 % agarose solution. Next, 2.5 ul/ 100 ml ethidium bromide (Sigma Aldrich Chemie 
GmbH, Germany) was added to the solution. The agarose gel was cast in a gel tank, any 
bubbles were removed by a sterile pipette tip, the gel comb was added and the gel 
allowed to set (Kean, 2006). The agarose gel (1 %) was added into a horizontal tank 
containing TBE-buffer. A 100 bp DNA Ladder was used as a DNA standard marker for 
the evaluation of the template sizes. 17 μl (= 37.5 ng) of each amplified cDNA product 
were carefully inserted in the already preformed corned gel chambers. Gel 
electrophoresis was carried out at an electrical field of 120 V. The cDNA, which is 
negatively charged by comprised phosphates, migrates and separates based on their size 
towards the anode, after applying the electrical field of 120 V. Distributed amplicons 
were visual verified by an UV-Transluminator to confirm the expected size and the lack 
of unspecific PCR products.  
 
3.2.7.7 Real-time quantitative PCR (RT-qPCR) 
The real-time qPCR, a sensitive and precise method to quantify the relative expression 
of each gene of interest (Derveaux et al., 2010), was performed with the Corbett Rotor 
Gene 6000 (Qiagen, Germany). Each sample was analysed in duplicates in a total 
reaction volume of 20 μl containing 4 μl of cDNA and 16 μl of Master Mix. The 16μl 
Master Mix was composed as follows: 10 μl of SensiMix SYBR NO-ROX Kit (Bioline, 
UK), 0.4 μl (10 pmol/ ul) of each forward/ reverse primer and 5.2 μl of nuclease-free 
water. Pipetting of the RT-qPCR reactions was realised with the CAS 1200 Robotics 
(Qiagen, Germany) to ensure maximum accuracy and replicability. Each run started with 
95 °C for 10 min to activate the Hot- Start DNA polymerase, followed by 40 cycles of 
following conditions: 95 °C for 15 seconds for denaturation, 60 °C for 20 seconds for 
annealing of the primers, and finally 72 °C for 20 seconds for complementary 
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elongation. Primer specificity of each target gene was examined by the melt curve 
analysis and the size verification by gel electrophoresis (Bustin et al., 2005, Wang & 
Seed, 2003). The efficiency (E) of the primers were evaluated by a standard curve based 
on a serial dilution of the target gene containing cDNA (3 ng; 1.5 ng; 0.75 ng; 0.375 ng) 
(Kubista et al., 2006). The measured cycle threshold values (Ct) were plotted against 
fluorescence in a diagram and analysed using the equation: E= (10 ( -1/slope))-1 (Kubista 
et al., 2006) with the help of the Rotor Gene 6000 Software (Qiagen, Germany). All 
designed primers (Table 7.2/ Fig. 4) demonstrated an efficiency of 1, except the primer 
of MKP-1 = 0.87. At the end of each run of the RT-qPCR, a melt curve program followed 
by continuous fluorescence measurement under following conditions: increasing 
heating rate of 1 °C per 5 seconds from 72°C to 95°C. The melt curve characterizes the 
specific chemical bond-properties of each amplicon, examined by increasing 
temperature leading to denaturation of the dsDNA. Denaturation depends on the length 
and sequence of the amplicons. The melting point is a specific point of temperature 
where half of the dsDNA already separates in single DNA strands. The SensiMix SYBR 
NO-ROX Kit contains a SYBR Green-intercalating dye. The dye gets excited and 
fluoresces when intercalated into dsDNA. The fluorescence emission of SYBR-green 
can be measured at a wavelength between 450-510 nm. During the melt curve analysis, 
fluorescence of the intercalated SYBR dye decreases, caused by the loss of helical 
structure of the DNA. The continuous fluorescence measurement plots derivative 
fluorescence (dF/ dT) versus temperature into a diagram. At a specific temperature, the 
derivative fluorescence increases to a sharp slope, defined as the melting point. The 
presence of unintended PCR-products or primer dimers can be detected by the 
occurrence of additional peaks in the melt curve analysis, leading into further primer-
design or PCR optimization by increasing Tm or changing the amount of magnesium in 
the Master Mix. A RT-negative sample was used as negative control to detect the 
presence or absence of contaminating genomic DNA. In the final experiments no 
genomic DNA or primer dimers were detected. Analysis of the relative expression in 
RT-qPCR was performed as follows: 
In PCR, ideally the amount of amplicons doubles each cycle, leading to exponential 
amplification. In RT- qPCR, a step to analyse newly amplified dsDNA by detection of 
fluorescent intercalating SYBR-Green dye was inserted after each cycle. Measured data 
were plotted into a diagram depicting the fluorescence versus the temperature (Fig. 7). 
To analyse the amount of amplified products in relation between treated and untreated 
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samples of equal conditions, differences in Ct-values were documented for further 
analyses after setting a cycle-threshold (Ct). The cycle-threshold, defines the cycle 
number where the signal of SYBR-Green fluorescence reaches exponential phase. 
Which is usually set at the exponential phase of the curve. The relative expression of the 
target genes was analysed using a modified Pfaffl method (Derveaux et al., 2010, Pfaffl, 
2001, Rieu & Powers, 2009). To determine significant differences in the mRNA 
expression between different experimental conditions, the relative quantity for each 
sample was calculated using following equation: E=10(-1/ct), here E is the efficiency and 
ct the threshold cycle (Pfaffl, 2001). The relative quantity for each sample was then 
normalized to the geometric mean of two house-keeping genes in this experiment: 
hypoxanthine phosphoribosyltransferase1 (HPRT1) and peptidylpropyl isomerase B 
(PPIB) (see table 7.2 and figure 4). Reference genes (or housekeeping genes) are stably 
expressed and should not change their expression among the experimental conditions 
tested.  The stability of the housekeeping genes was assessed using the BestKeeper 
algorithm (Pfaffl et al., 2004). The normalised relative quantity values were log2-
transformed for further statistical analysis with GraphPad Prism 5.0. All analysed 
sample groups were either analysed in the same run in duplicates or calibrated by an 
internal control in duplicates. 
 
Fig. 7: Fluorescence of amplified RT-qPCR products, investigating the expression of 
IL6 in different conditions 
 
Fig. 7: The figure shows a RT-qPCR plot determining changes in IL6-expression by 
investigating different samples: (A) Control, (B) C. albicans (UV) ; (C) C. albicans (UV) + 
atRA; (D) RT-negative. The diagram shows the cycles versus fluorescence of the cDNA for 
different conditions. RT-qPCR was performed by the Corbett Rotor Gene 6000.  
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3.2.8 Flow cytometry  
To analyse the atRA-induced changes of Dectin-1 and TLR2 expression on the surface 
of the monocytes flow cytometry was used (Herzenberg et al., 2002).  
In flow cytometry, fluorochrome coupled antibodies are measured by lasers and 
detectors, detecting the fluorochrome characteristic emission wavelength (Baumgarth 
& Roederer, 2000, Herzenberg et al., 2002). In our study, FITC- coupled antibodies and 
APC-coupled antibodies were used (FITC ~ 525 nm; APC~ 660 nm). Light scatter 
analysis gives additional information about granulation and size of the cells. For flow 
cytometry analysis, monocytes were harvested after 12 hours, 18 hours and 24 hours of 
stimulation. Viability of the monocytes was ≥ 90%, as evaluated by trypan blue staining 
and propidium iodide 1.0 mg/ ml (VWR International, Germany). The cells were 
harvested and washed with cold flow cytometry buffer (DPBS containing 2 % FCS), 
filled up to an amount of 1.5 * 106 cells/ 400 μl buffer and added in 96- well plates by 
an amount of 3.75 * 105 cells/ 100 μl buffer/ well (Jouault et al., 2006). 
Cells of each stimulation case were stained with either Dectin-1 antibodies or TLR2 
antibodies separately (Table 9). Antibodies are conjugated with a fluorescent marker for 
measurement and visual verification. Cells stained with Anti-Dectin-1 antibody were 
conjugated with APC labelled goat anti-mouse antibody in a secondary step, whereas 
the Anti-TLR2 antibody was already FITC conjugated, so no secondary step was needed 
(Table 9) (Ambarus et al., 2012, Elsori et al., 2011, Li et al., 2012).  
Each staining step took about 30 min of incubation time, followed by several washing 
steps and further incubation periods with flow cytometry buffer. All cells went through 
all washing steps and incubation periods, incubated with either antibodies or flow 
cytometry buffer to receive results under equal conditions. Preliminary experiments 
using monocytic THP-1 cells and monocytes gave information about the adequate 
concentration of the antibodies, fluorochrome and isotypes according to the size of the 
cell population (Hulspas et al., 2009, Tung et al., 2007). Unstained samples were used 
as negative control to take into account the auto fluorescence of the cells (Hulspas et al., 
2009). Specificity of the antibodies was verified by isotype control samples (Hulspas et 
al., 2009, Tung et al., 2007). Samples were measured in a FACS ARIA II machine (BD 
Biosciences, Germany). The flow cytometry data were analysed according to previous 
studies with the help of the FlowJo 7.6.4. Software (Herzenberg et al., 2006, Tung et 
al., 2007). The mean of the fluorescence intensity (MFI) of each case was normalized 
to the MFI of the corresponding unstained sample (Dendrou et al., 2009). The relative 
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mean fluorescence intensity of the TLR2 and Dectin-1 of four independent experiments 
was analysed, each sample verified in triplicates.  
 
3.2.9 Cytokine measurement 
To quantify the amount of secreted cytokines by monocytes after challenging with UV- 
inactivated C. albicans yeasts for 16 hours, the supernatant of the cell culture was 
analysed with the use of commercially available ELISA-Kits: TNFα, IL6, IL12b, IFN-
β and IL10 (Table 12). The concentration of each of the secreted cytokines of different 
conditions of five independent experiments was analysed, each sample verified in 
triplicates. For quantitative enzyme-linked immunosorbent assay (ELISA) a capture 
antibody of the target cytokine was pre-coated on Maxisorp F 96-well plates (VWR 
International, Germany) based on manufacturer´s instruction (Table 12). After a 
washing step, an equal amount of each supernatant was added to each well. The ideal 
dilution of the supernatant was used in each case and all samples were analysed in 
triplicates. Furthermore, a positive control with a known concentration and its serial 
dilution was included for further data analysis. The diluent was used as a negative 
control and for background correction. After an incubation period of the supernatant 
based on manufacturer´s instructions several washing steps followed. Same procedure 
was always repeated after adding a new module of the ELISA Kit. The next module of 
the ELISA Kit was the addition of the detection antibody, followed by the sensitive 
enzyme linked with a secondary antibody in a following step. This secondary antibody 
connects to the detection antibody. In one of the last steps, the substrate was added. The 
substrate is degraded into fluorescent products by the already added and linked enzyme. 
The higher the amount of cytokines in a well, the more quantity of linked enzyme will 
be in a well, degrading the substrate. Consequently, more fluorescent products are 
present. Before measuring the optical density (OD) at indicated wavelength in the 
Infinite M200 reader (Tecan, UK), a stop solution was transferred to each plate to 
prevent eventual saturation of the signal. The concentration of cytokines was calculated 
in each case with the help of the analogue standard curve by five-parameter logistic 
analysis using Magellan v.6 Software (Tecan, UK) (Findlay & Dillard, 2007).  
 
3.2.10  Statistical analysis 
Statistical analysis was performed using the Graph Pad version 5 software (San Diego, 
US). One-way ANOVA (Vanoirbeek et al., 2013) with Dunnett´s post-hoc test or two-
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sided t-test were used for statistical analysis. For flow cytometry, data were assessed by 
the Page´s L Test.  
The level of statistical significance was set at * p ≤ 0.05; ** p<0.01; *** p<0.001. 
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4.    Results 
 
4.1  AtRA is able to modulate the C. albicans-induced cytokine production in human 
monocytes 
   To ascertain the modulatory effect of atRA on the immune response induced by  
C. albicans, monocytes facing UV-inactivated yeast in presence or absence of 1 μM atRA 
were analysed. In a first assay, alteration in the expression of the pro-inflammatory 
cytokines TNFα, IL6, IL12b and the anti-inflammatory cytokine IL10 was analysed at 
transcriptional level by Real-Time qPCR. 
After 5 hours of incubation with UV-inactivated C. albicans yeasts, we could observe a 
significant increase of all four cytokines on mRNA level (Fig. 8A). However, in the 
presence of atRA in the cell culture medium a significant suppression of the pro – 
inflammatory cytokines occurred. We observed a significant downregulation of TNFα 
from a 78-fold mRNA expression upon stimulation with C. albicans, to a 21-fold mRNA 
expression by the influence of atRA. Equal results were observed for the other two pro-
inflammatory cytokines IL6 and IL12b. The presence of atRA led to a significant 
downregulation of up to 94 % and 97.9 % of the C. albicans-induced mRNA expression, 
respectively.  This inhibitory effect of atRA on all three pro-inflammatory cytokines seem 
to occur in a dose-dependent manner, already observed in very low concentration like 
0.01 μM atRA (Fig. 8B).  
The expression of the anti-inflammatory cytokine IL10 was clearly increased by the 
stimulation with C. albicans. The same response was also observed for addition of atRA 
alone (data not shown). Nevertheless, the presence of atRA in the culture medium while 
monocytes were challenged with UV-inactivated C. albicans yeasts showed no effect at 
transcriptional level. However, all-trans retinoic acid seems to modulate the expression 
of the pro-inflammatory cytokines TNFα, IL12b, IL6 in the C. albicans infection.  
Next, we investigated the impact of atRA on the protein level of these pro-inflammatory 
cytokines and the anti-inflammatory cytokine IL10 in C. albicans infection. We measured 
the level of the cytokines TNFα, IL6, IL12b and IL10 in the supernatant of the cell culture, 
secreted by monocytes after 16 hours of fungal stimulation alone or in presence of 1 μM 
atRA (Fig. 9) with the use of specific ELISA-Kits.  
Upon C. albicans infection, a clear increase in all secreted pro-inflammatory cytokines 
could be seen. In the presence of 1 μM atRA, we observed a significant downregulation 
of TNFα by a mean of 72 %, IL6 by a mean of 68.1 % and IL12b by a mean of 84.4 %. 
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In contrast, addition of atRA to the culture medium did not induce a change in protein 
level of the anti-inflammatory cytokine IL10.  
Summarizing, all-trans retinoic acid seems to modulate the expression of the pro-
inflammatory cytokines TNFα, IL12b, IL6 in the C. albicans infection. Moreover, atRA 
seems to be an anti-inflammatory modulator in monocytes upon C. albicans infection. 
Next, we investigated whether atRA exerts its modulatory role upon cytokine expression 
by the modulation of PRRs like Dectin-1. 
 
Fig.8:  Modulatory effect of atRA on monocytes upon cytokine expression in the 
presence of C. albicans for 5 hours 
 
Fig. 8A: The graphs show the C. albicans-induced mRNA expression of the TNFα, IL6, IL12b 
and IL10 in the presence or absence of 1 μM atRA. Results are shown as mean fold expression 
+/- SEM of five independent experiments. * p<0.05; ** p<0.01; *** p<0.001. 
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Fig. 8B: Chart describes the inhibitory impact of different concentrations of atRA (from 0.01 μM 
to 10 μM) on the pro-inflammatory cytokine mRNA level upon C. albicans infection.  
 















Fig. 9: For 16 hours, human monocytes were challenged with UV-inactivated C. albicans yeast 
in the presence or absence of 1 μM atRA. Supernatants of five independent experiments were 
collected and examined for variances in cytokine release with the use of specific ELISA Kits. 
Results are shown as mean concentration (pg/ ml) +/- SEM.   
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4.2 AtRA modulates the Dectin-1-mediated cytokine production in human monocytes 
To address specifically the effect of atRA on the Dectin-1-mediated response, we used 
beads coated with β-1.3 glucan as pro-inflammatory trigger. These β-1.3 glucan beads 
mimic the shape of C. albicans yeast, but inducing a specific Dectin-1 response. 
Human monocytes were incubated with β-1.3 glucan beads for 5 hours and 16 hours in 
the presence or absence of 1 μM atRA, monitored by microscopy.  
As shown in figure 10, we could observe the attachment of the beta-glucan beads to the 
monocytes after 5 hours of incubation (Fig. 10). At this time point, we measured the 
expression of cytokines at transcriptional level by RT-qPCR. Monocytes treated with β-
1.3 glucan beads showed a significantly increase in the gene expression of the pro-
inflammatory cytokines TNFα, IL6 and IL12b. However, the presence of atRA led to a 
clear downregulation of the specific Dectin-1-mediated cytokine expression of all pro-
inflammatory cytokines: near to the initial point by the inhibition of 73 % and 86.6 % for 
TNFα and IL12b respectively and in the case of IL6 an inhibition up to 65.2 % (Fig. 11A). 
 
Fig 10:  Monocytes treated with β-1.3 glucan coated beads in presence or absence of atRA 
monitored under microscope at several time points.    
 
Fig. 10A-B: The images show monocytes treated with β-1.3 glucan coated beads in the presence 
of atRA at zero hour (A) and five hours (B) of incubation. Monocytes were monitored under 
microscope at several times.   
 
In the next step, we investigated the effect of atRA at the protein level in the Dectin-1-
mediated cytokine response. We measured the level of the secreted cytokines TNFα, IL6, 
IL12b and IL10 in the supernatant of the cell culture with the use of specific ELISA-Kits 
after 16 hours of stimulation in the same experimental conditions (Fig. 11B). We observed 
a clear downregulation of the β-1.3 glucan triggered cytokine release in the presence of 
B A 
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atRA by an inhibition of 88.4 %, 92.2 % and 37.4 % for TNFα, IL6 and IL12b 
respectively. Furthermore, we investigated the impact of atRA at the anti-inflammatory 
cytokine IL10 in the Dectin-1-mediated response. In the presence of atRA, we observed 
a significant upregulation of the already enhanced IL10 cytokine release by the β-1.3 
glucan beads (Fig. 11).  
These findings show clearly the anti-inflammatory impact of atRA on the specific Dectin-
1-induced immune response at transcriptional and post-translational level. Since we could 
observe a modulation of the Dectin-1 function in terms of receptor-dependent cytokine 
production, we next investigated whether atRA is able to regulate the expression of this 
pattern recognition receptor itself. 
 
4.3    AtRA modulates the expression of relevant PRRs 
 
4.3.1 The expression of Dectin-1 is modulated by atRA 
We investigated the variation in Dectin-1 mRNA expression in monocytes upon  
C. albicans infection in presence or absence of atRA by RT-qPCR after 5 hours and 16 
hours of stimulation. Our results show that the addition of atRA led to a significant 
reduction of the Dectin-1 expression in human monocytes upon C. albicans infection after 
5 hours and 16 hours of stimulation. Interestingly, we could also observe that C. albicans 
alone was able to downregulate its recognizing pattern recognition receptor in a 
significant manner (Fig. 12A). To confirm these findings at protein level, the impact of 
atRA on Dectin-1 expression upon C. albicans infection was determined by flow 
cytometry over a one-day period: examinations were done after 12 hours, 18 hours and 
24 hours of stimulation (Fig. 12B-C). As shown in figure 12B, we could observe a vitamin 
A-mediated drop of the expression of Dectin-1 on the cell surface of the human 
monocytes at protein level. When we analysed the inhibitory effect of atRA on the Dectin-
1 receptor expression over time, we could observe an increasing inhibitory effect, with a 
maximum at 24 hours of stimulation, confirming the results at transcriptional level. The 
inhibitory effect of atRA on the Dectin-1 expression could also be observed in the absence 
of inflammatory trigger. Stimulation of monocytes with 1 μM atRA alone lead to a 
downregulation of the receptor, similar to the one observed in the infection model. This 
effect could be confirmed at both transcriptional and protein level (Fig. 13). Since atRA  
is known to play a key role in differentiation processes, we investigated whether the 
observed modulatory effect of atRA on the Dectin-1 expression might be due to the 
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differentiation of monocytes into dendritic cells (DCs) or macrophages. However, 
monocytes terminally differentiated into monocytic-derived DCs by stimulation with 
GM-CSF and IL-4 showed a comparable impact of atRA on the Dectin-1 expression (Fig. 
14) 
Fig. 11: Modulatory effect of atRA on the Dectin-1-mediated cytokine expression  
and secretion  
Fig. 11A-B: Monocytes were stimulated with β-1.3 glucan coated beads for 5 hours (A) and 16 
hours (B) to assess the impact of atRA on the Dectin-1-mediated cytokine production.                        
Fig. 11A: Monocytes were challenged with β-1.3 glucan beads in the presence or absence of  









































































































































Fig. 11B: Measurement of the secreted cytokines after 16 hours of stimulation, expressed as mean 
concentration (pg/ ml) +/- SEM of five independent experiments. 
Fig. 11A-B: * p<0.05; ** p<0.01; *** p<0.001   
 
Fig. 12: Modulatory role of atRA on the expression of the Dectin-1 receptor in human 















Fig. 12A: The figure shows the mean mRNA expression +/- SEM of the Dectin-1 receptor of 
five independent experiments in presence or absence of 1 μM atRA in fungal infection after 5 












































Fig. 12B: The figure shows a flow cytometry plot of Dectin-1 APC after 24 hours of stimulation 
















Fig. 12C: The diagram shows the relative mean fluorescence intensity (MFI) of Dectin-1 over a 
one-day period. The relative MFI is defined as the MFI of the monocytes stimulated by  
C. albicans and 1 μM atRA divided by the MFI of the monocytes challenged only with UV-
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Fig. 13: Modulatory effect of atRA alone on the transcriptional and post-translational 
















Fig. 13A: The mRNA expression of Dectin-1 after 5 hours of stimulation with 1 μM atRA. Results 
are shown as mean fold expression of three independent experiments. For statistical analysis t- 
















Fig. 13B: Dectin-1 expression on the cell surface of human monocytes was analyzed by flow 
cytometry after 24 hours of incubation with 1 μM atRA. 







































Fig. 14: Modulatory impact of atRA on the Dectin-1 expression in monocytic-derived 















Fig. 14: Human monocytes were stimulated with GM-CSF and IL-4 for one week. Terminally 
differentiated monocytic-derived DCs were stimulated with 1 μM atRA for 5 hours before 
transcriptional analysis of Dectin-1. Analysis was performed in three independent experiments.  
* p<0.05  
 
4.3.2 Impact of atRA on the expression of Dectin-1 co-receptors 
Since several receptors are known to cooperate with Dectin-1, leading to an amplification 
of a specific and effective host defence, we next investigated whether atRA could also 
have an effect on the expression of the known co-receptors of Dectin-1:TLR2 and Gal-3.  
As shown in figure 15, we observed an influence of both atRA and C. albicans on the 
mRNA expression of these two PRRs on monocytes after stimulation periods of 5 hours 
and 16 hours. At both times, we observed that C. albicans lead to an upregulation of the 
expression of TLR2 and Gal-3. Nevertheless, when atRA was added, we observed a 
significant downregulation.  
 
4.3.3 Early regulation of PRRs by atRA 
Our results show that the mRNA expression of both Dectin-1 and its co-receptors are 
downregulated in the presence of atRA. This raised the question whether the drop in 
cytokine expression could be attributed to the downregulation of these receptors. 
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To investigate further this causality, we next investigated the impact of atRA on the 
expression of the receptors at earlier time points. We investigated the expression of the 
surface proteins Dectin-1 and TLR2 by flow cytometry and Gal-3 by western blot after 4 
hours of stimulation with C. albicans in presence or absence of 1 μM atRA. Although we 
found no variation in the post-translational expression of TLR2 and Gal-3, an incipient 
decrease in the Dectin-1 expression on the cell surface could already been observed after 
4 hours, where both atRA and C. albicans were able to downregulate the expression of 
the Dectin-1 receptor (Fig 16A-C).  
 
Fig. 15: Modulatory impact of atRA on the mRNA expression of TLR2 and Gal-3 upon  
C. albicans infection 
Fig. 15: Both figures show the mean relative mRNA expression +/- SEM in monocytes of five 
independent experiments after 5 hours and 16 hours of incubation with C. albicans in presence or 
absence of 1 μM atRA. *p<0.05; **p<0.01; ***p<0.001  
 
4.3.4 Short versus long atRA pre-treatment 
We have observed that the effect of atRA on Dectin-1 expression in fungal infection is 
highest after 24 hours of stimulation. Therefore, we compared the inhibitory power of 
atRA on larger pre-incubation periods of 24 hours as compared to only 0.5 hours.   
Surprisingly, a longer pre-treatment of atRA in monocytes up to 24 hours led to a reduced 
effect in cytokine inhibition (Fig. 17). Whereas atRA showed a slight reduction on the 
inhibitory effect of 9.3 % and 16.52 % on the expression of TNFα and IL12b respectively. 
The impact on the IL6 expression was reduced up to 63.3 % after 24 hours of stimulation. 
According to our data, atRA seems to show its highest anti-inflammatory effect at 
transcriptional level after a short period of pre-stimulation, suggesting a causal direct 
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molecular mechanism.  
 
Fig. 16: Post-translational modification on the PRRs Dectin-1, TLR2 and Gal-3 in 
monocytes by atRA at an early stage of the C. albicans-induced inflammation.  
Fig 16A-C: Modification of the expression levels of the PRRs Dectin-1, TLR2 and Gal-3 in 
monocytes by 1 μM atRA upon C. albicans infection were investigated either by flow cytometry 
(9A-B) or by western blot (9C) after 4 hours of incubation. Three independent experiments were 
realized. 
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Fig. 17: Modulatory effect of atRA on the cytokine expression of TNFα, IL6 and IL12b after 
different periods of pre-treatment in fungal infection 
Fig. 17: Monocytes were pre-stimulated with atRA for either 0.5 hours or 24 hours before 
challenged with UV-inactivated C. albicans yeast for 5 hours. The figure shows the inhibitory 
impact of atRA on the expression of the pro-inflammatory cytokines TNFα, IL12b and IL6 in 
percent +/- SEM of three independent experiments.  
 
4.4    AtRA exerts its anti-inflammatory effect in a RAR-dependent manner 
 
4.4.1 RAR expression pattern in human monocytes 
AtRA exerts most of its biological function by binding one of the RARs. Therefore, we 
investigated if the effect of atRA is RAR-dependent. First, we investigated the expression 
pattern of all known RARs in unstimulated monocytes. Monocytes of all five healthy 
donors showed an expression of both RARα and RARγ, whereas no expression of RARβ 
was observed (Fig 18A).   
 
4.4.2 Agonist/ antagonist experiments 
After determining the expression profile of retinoic acid receptors in monocytes, it 
remained unclear whether one of these two expressed retinoic acid receptors is 
responsible for the atRA -mediated modulation on the immune response against  
C. albicans. Therefore, we investigated the gene expression of the pro-inflammatory 
cytokines TNFα, IL6, IL12b and the PRR Dectin-1 in monocytes stimulated with either 
specific RARα- or RARγ-Agonists (Fig. 18B).  
Both agonists were able to resemble the effect of atRA in a significant manner for TNFα, 
IL12b and Dectin-1. For IL6, only the RARγ-agonist was able to lead to a significant 
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downregulation of this cytokine (Fig. 18B). Moreover, we next used specific antagonists 
to confirm that the C. albicans-mediated activation of gene expression could be restored 
in their presence. The antagonists of both RARs restored the C. albicans-induced cytokine 
expression, at least in part in a significant manner. Nevertheless, the expression level of 
Dectin-1 was not altered by the addition of any of the RAR-antagonists, suggesting an 
additional RAR-independent mechanism in the atRA -mediated anti-inflammatory 
immune response. Overall, these data suggest an involvement of both receptors in the 
modulatory role of atRA in the C. albicans-induced immune response. 
 
Fig. 18: Expression profile of retinoic acid receptors in unstimulated human monocytes, and 
analysis of their involvement in the atRA-mediated modulation of the immune response 
against C. albicans. 
Fig. 18A: The expression profile of RARs was analysed by agarose gel electrophoresis of PCR 
products from five different donors (M1-M5).  PBMCs were used as positive control for the 
expression of RARα and RARγ, whereas NHBE cells were used as positive control for RARβ. 
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Fig. 18B: Analysis of the involvement of the retinoic acid receptors in human monocytes in 
the atRA-mediated modulation of the immune response against C. albicans. 
 
 
Fig. 18B: Specific RAR agonists (RARα: BMS753; RARγ: BMS 961) and antagonists  
(RARα: BMS 195614; RARγ: MM11253) were used to address the specific involvement of each 
RAR on the atRA -mediated downregulation of TNFα, IL6, IL12b and Dectin-1. Data are shown 
as mean values +/- SEM, assessed from five independent experiments. For statistical analysis, 
One-Way ANOVA and Dunnett's Multiple Comparison Test were used. 
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4.5  Effect of atRA on the IFN type I response against C. albicans  
 
4.5.1  AtRA modulates the IFN-β expression upon C. albicans and β-glucan challenge 
After investigating the effect of atRA on the classical cytokine response in fungal 
infections, we next investigated its potential impact on the IFN type I response. In our 
laboratory, Bräuer already reported the capability of atRA to reduce the C. albicans-
induced IFN-β production in human monocytes (Bräuer, 2013). We replicated these data. 
Moreover, we analysed the impact of atRA on the IFN-β expression upon β-1.3 glucan 
stimulation.  
Monocytes challenged with UV-inactivated C. albicans yeast for a period of 5 hours, 
showed a clear up-regulation in IFN-β expression. The addition of 1 μM atRA led to a 
clear suppression of the C. albicans- triggered IFN-β expression (Fig 19A). A similar 
result was observed when monocytes were challenged with β-1.3 glucan instead of  
C. albicans. Again, we could observe a downregulation of the β-1.3 glucan-induced 
IFN-β expression (Fig. 19B). 
 
4.5.2 AtRA modulates the expression of several members of the IFN type I pathway 
To understand how atRA exerts its function in the IFN type I pathway in  
monocytes upon C. albicans infection, we investigated the influence of atRA on the 
complete IFN type I pathway at transcriptional level by RT-qPCR (Fig.20). 
In this analysis, we included the receptors and the most important regulating factors for 
IFN type I signalling.   
After 5 hours of incubation with UV-inactivated C. albicans yeasts, we observed an 
upregulation of STAT1, STAT2, IRF1, IRF7 and IRF9, whereas the expression of 
IFNAR1 and IRF5 was not altered after stimulation (Fig. 20). In addition of atRA, we 
observed a downregulation of the expression of all C. albicans-induced genes as well as 
a downregulation of the expression of IRF5. However, the expression of IFNAR1 was 
not altered (Fig.20).   
In addition, we also investigated the effect of atRA on two additional TLRs which might 
be involved in the fungal-mediated IFN type I response: TLR7 and TLR9. In our 
experiments, we observed a significant downregulation of the mRNA expression of TLR7 
in the presence of atRA, whereas no alteration on the expression of TLR9 in monocytes 
challenged with UV-inactivated C. albicans yeast occurred (Fig. 21). Interestingly, the 
presence of C. albicans alone already led to a downregulation of both TLRs at 
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transcriptional level (Fig.21). 
 
Fig. 19: The modulatory effect of atRA on the IFN-β expression in human monocytes upon 
C. albicans (A) and β-1.3 glucan (B) stimulation 
Fig 19A-B: Relative mRNA expression was analysed after 5 hours of incubation with either UV- 
inactivated C. albicans yeast or β-1.3 glucan coated beads in presence or absence of 1 μM atRA. 
Data are shown as mean mRNA expression +/- SEM of five independent experiments. For 
statistical analyses, One-Way ANOVA and Dunnett's Multiple Comparison Test were used.  
* p<0.05; ** p<0.01; *** p< 0.001  
 
Overall, our data suggest that atRA is able to modulate most of the genes involved in the 
IFN type I pathway. Moreover, also one of the most important PRRs leading to an IFN 
type I response (TLR7) was downregulated by atRA.  
Next, we addressed whether atRA was capable to modulate the IFN-β induction mediated 
by these two receptors, TLR7 and TLR9.  
Therefore, we stimulated PBMCs for 0.5 hours with or without 1 μM atRA before 
stimulating for 5 hours with either 5 μg/ ml Imiquimod, a specific ligand of TLR7 or  
10 μg/ ml CpG Type A, a synthetic oligonucleotide known to stimulate specifically the 
TLR9. We observed a clear induction of the IFN-β expression at transcriptional level by 
the stimulation of the TLR7 and TLR9. Interestingly, the addition of atRA led to a 
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Fig. 20: Immunodulatory role of atRA in the IFN type I pathway upon C. albicans infection 
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Fig. 20:  Expression profile of the most important components of the IFN type I pathway were 
analysed at transcriptional level by RT-qPCR after monocytes were challenged with C. albicans 
UV- inactivated yeasts for 5 hours in presence or absence of 1μM atRA. Data are shown as mean 
mRNA expression +/- SEM of five independent experiments. For statistical analyses, One-Way 
ANOVA and Dunnett's Multiple Comparison Test were used.  
* p<0.05; ** p<0.01; *** p<0.001; ns – not significant  
 
Fig.21: Impact of atRA on the expression of TLR7 and TLR9 mRNA upon  
C. albicans infection 
Fig. 21: Expression profile of TLR7 and TLR9 analysed at transcriptional level by RT-qPCR after 
monocytes were challenged with UV- inactivated C. albicans yeast for 5 hours in presence or 
absence of 1 μM atRA. Data are shown as mean mRNA expression +/- SEM of five independent 
experiments. * p<0.05; ** p<0.01; *** p<0.001; ns – not significant 
 
Fig. 22: Impact of atRA on the TLR7- and TLR9-mediated IFN-β expression  
 
Fig. 22: PBMCs were stimulated for 5 hours with either 10 μg/ ml CpG Type A or 5 μg/ ml 
Imiquimod in presence or absence of 1 μM atRA. The data are shown as mean mRNA expression 
+/- SEM of three independent experiments. For statistical analyses, One-Way ANOVA and 



















































































































Candida species are one of the most common fungal pathogens of humans and the causative 
agents of superficial and invasive candidiasis, giving rise to severe morbidity and mortality in 
millions of individuals worldwide (Naglik, 2014).  
Since several centuries, vitamin A deficiency (VAD) has been associated with a reduced 
immune response affecting the health and survival of infants, young children and pregnant 
women (West, 2003). Moreover, worldwide VAD is reported to be the third most frequent 
nutritional problem after protein-energy malnutrition and iron-deficiency and was declared as 
a public health care problem by the WHO in the years 1990-1993 (Chandra, 1979). 
In VAD, especially, viral and bacterial infections are reported to cause high mortality among 
infants and young children (Ball, 2004, Chandra, 1988, Dollé & Niederreither, 2015, Mayo-
Wilson et al., 2011). In fungal infection, nothing is known.  
Ribeiro Nogueira et al. showed an alteration in retinol in human septic patients treated in ICUs 
in Brazil (Ribeiro Nogueira et al., 2009). Nevertheless, the role of vitamin A and its mechanism 
in fungal infections are still unknown. 
Our aim was to investigate the function of vitamin A in the C. albicans-induced inflammatory 
response. Furthermore, we wanted to investigate the modulatory role of atRA on the expression 
and function of Dectin-1 and other relevant PRRs.  
We could demonstrate for the first time the modulatory role of atRA in human monocytes in 
the C. albicans-triggered inflammation, modulating the expression of Dectin-1 and its co-
receptors as well as regulating the function of Dectin-1. 
Furthermore, we investigated the effect of atRA on the C. albicans- induced IFN I pathway 
(Smeekens et al., 2013). We could observe a downregulation of several important regulatory 
proteins and transcription factors of the IFN I pathway at transcriptional level.  
AtRA has a clear immunomodulatory impact upon C. albicans- induced immune response in 
human monocytes. 
In our first experiment, monocytes were challenged with UV-inactivated C. albicans yeast for 
5 hours and 16 hours alone or in the presence of 1 μM atRA. In the presence of atRA metabolite, 
we observed a clear drop of the C. albicans-induced pro-inflammatory cytokines TNFα, IL6 
and IL12b at transcriptional and post-translational level measured by real-time qPCR and 
ELISA.  
Since Dectin-1 is one of the most important PRRs in C. albicans infection, inducing 
phagocytosis and complex pro-inflammatory antifungal immune response, we investigated the 
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role of atRA on the expression of this antifungal PRR and its specific signalling pathway. 
Therefore, monocytes were incubated with β-1.3 glucan coated beads, a specific Dectin-1 
ligand found on the cell wall of C. albicans (Brown, 2006, Esteban et al., 2011, Gow et al., 
2012).   
We observed a significantly increased Dectin-1-mediated cytokine release upon stimulation 
with β-1.3 glucan coated beads. However, in the presence of atRA, we observed a clear 
suppression of the β-1.3 glucan-induced pro-inflammatory cytokine production at 
transcriptional and protein level.  
Furthermore, we investigated the effect of atRA on the IL10 production in the same settings. 
We observed a clear upregulation of the IL10 expression at transcriptional level in the presence 
of C. albicans and while monocytes were stimulated with β-1.3 glucan coated beads. Although 
we observed no alteration in the IL10 expression in presence of atRA upon C. albicans infection 
as compared to the effect of C. albicans alone, we were able to detect an increased IL10 
production in the presence of atRA when the cells were challenged with β-1.3 glucan beads.  
Wang et al. has already shown that vitamin A is able to improve the anti-inflammatory response 
in LPS- induced infection (Wang et al., 2007). Consequently, we investigated the effect of atRA 
on the IL10 expression alone. Indeed, we could observe an upregulation of IL10 expression 
equal to the effect of C. albicans alone. We suggest that the IL10 expression induced by C. 
albicans has already reached a saturated state, so that no further additive effect in the presence 
of atRA can be observed. Overall, atRA seems to modulate the C. albicans- and Dectin-1-
induced pro-inflammatory cytokine production in an anti-inflammatory manner. Furthermore, 
atRA seems to increase the anti-inflammatory IL10 cytokine expression until a saturated state. 
These data raised the question, whether atRA might regulate the pro-inflammatory cytokine 
response by modulating the Dectin-1 expression. A recent study reported an ability of vitamin 
D3 to modulate the pro-inflammatory cytokine response in  
C. albicans infection by the regulation of PRRs (Khoo et al., 2011a). We observed a significant 
down-regulation of Dectin-1 at transcriptional level after 5 hours and 16 hours in the presence 
of atRA while monocytes were challenged with C. albicans. Interestingly, C. albicans alone 
inhibited the Dectin-1 expression, a mechanism of C. albicans, which has not been reported 
until now, suggesting a new strategy of C. albicans to escape the immune response (Bone, 1996, 
Comstedt et al., 2009).   
Moreover, in the presence of atRA we observed a stronger inhibitory impact on the 
downregulated Dectin-1 expression at transcriptional level and by flow cytometry.  
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Nevertheless, this inhibitory impact of atRA seems not to be only challenge-dependent, since 
we observed a similar effect of atRA in the absence of C. albicans. 
Since vitamin A is known to be important in differentiation processes we investigated if this 
impact of atRA upon Dectin-1 expression might be due to differentiation of monocytes into 
dendritic cells (DCs) or macrophages (Chen & Ross, 2004, Mohty et al., 2003). We could 
observe that also terminally differentiated mature monocytic-derived DCs were sensitive to 
Dectin-1 modulation by atRA. Comparable to the effect observed on monocytes.  
Moreover, we could demonstrate an increasing suppressive effect of atRA on the Dectin-1 
expression over a long-term period. We suggest that the inhibitory immunomodulatory impact 
of atRA might thereby be sustained over a prolonged period of time.  
Furthermore, we observed a clear suppressive effect of atRA on the C. albicans-induced 
expression on the Dectin-1 co-receptors TLR2 and Gal-3. These results are in agreement with 
several reports, investigating an orchestration of several PRR like Dectin-1 and its co-receptors 
TLR2 and Gal3 leading to an increased efficiency in the anti-C. albicans host response (Esteban 
et al., 2011, Goodridge & Underhill, 2008, Jouault et al., 2006, Linden et al., 2013). These 
results raised the question, whether the observed atRA-mediated downregulation of Dectin-1 
and its co-receptors might be responsible for the drop in the pro-inflammatory cytokine 
production that we described. Since we observed a downregulation of all C. albicans-induced 
pro-inflammatory cytokines in the presence of atRA after 5 hours of incubation, we investigated 
the effect of vitamin A on Dectin-1 and its co-receptors at an earlier time point.  
Interestingly, we could already observe a downregulation of Dectin-1 on the surface of 
monocytes after only 4 hours of stimulation, although in a very incipient manner. At this stage, 
we observed no modulation of the Dectin-1 co-receptors at the post-translational level.  
Therefore, we cannot exclude that the atRA-mediated modulation of Dectin-1 might contribute 
at least in part to the drop of the C. albicans-induced cytokine production. Nevertheless, it is 
likely that other direct mechanisms play a prominent role in the early phase of the atRA-
mediated immunomodulation. This is supported by our observation that the short atRA pre-
treatment of 0.5 hours led to a stronger inhibitory effect than a long-term pre-treatment of 24 
hours, when the atRA-mediated Dectin-1 suppression reached its maximum. This is also in 
agreement with the observation that atRA modulates the LPS-induced immune response in an 
anti-inflammatory manner, a Dectin-1-independent immune response, at least in other innate 
immune cells like macrophages (Hong et al., 2014, Mehta et al., 1994).  
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In monocytes, so far only Wang et al. and Oeth et al have investigated the potential 
immunomodulatory role of atRA on LPS-induced responses (Oeth et al., 1998, Wang et al., 
2007). 
Whereas Oeth et al. did not observe any changes in the LPS-induced TNFα-response in the 
presence of vitamin A in human monocytes, Wang et al. reported only a slight downregulation 
of the LPS-induced TNFα and IL12 expression (Oeth et al., 1998, Wang et al., 2007). 
Nevertheless, we observed nearly a 100 % abrogation of the Dectin-1-mediated expression and 
secretion of TNFα, IL6 and IL12b. It might be interesting to investigate if the mentioned 
variances in cytokine inhibition might be related to the nature of immunological challenge. 
Furthermore, the TLR4/ LPS-signalling pathway differs fundamentally from the Dectin-1 
activation (Drummond & Brown, 2011). It might be possible, that different PRR- signalling 
pathways react with a different sensibility to the atRA modulation.   
Further studies are needed to investigate and understand the mechanism of the atRA-mediated 
modulation of the immune response.  
Since atRA mainly exerts its function by binding its NRs, the RARs, we investigated the 
expression of all known RARs in unstimulated human monocytes. We observed an existent 
expression of RARα and RARγ, whereas an expression of RARβ was absent. These results are 
in agreement with earlier studies (Fritsche et al., 2000). We used RAR-specific agonists and 
antagonists and could observe that both, RARα and RARγ are involved in the atRA-mediated 
downregulation on the C. albicans-induced cytokine production of TNFα, IL6 and IL12b. 
Nevertheless, the modulatory role of atRA on the Dectin-1-mediated immune response seems 
mainly to occur in a RAR-independent pathway.  
In recent years, investigations on the impact of vitamins on immunity and inflammation 
increased, especially in viral and bacterial infections (Demetriou et al., 1984, Khoo et al., 
2011b, López-Varela et al., 2002, Mangin et al., 2014, Mikirova & Hunninghake, 2014, Semba, 
1999). In fungal infections, less is known.  
Intense research on vitamin D3 upon fungal infection arose in the recent years, suggesting 
vitamin D3 as a potent immunomodulator in invasive candidiasis, being able to act either as pro- 
or anti-inflammatory agent in a dose dependent manner (Khoo et al., 2011a, Lim et al., 2015). 
Supplementation of vitamin A in vitamin A-deficient infants and children showed a reduced 
mortality in several viral and bacterial infections (Mayo-Wilson et al., 2011, West et al., 1991). 
Only few studies have investigated the effect of vitamin A in humans or animals suffering from 
sepsis. Demetriou et al. showed an increased protective role in the outcome of septic rats in the 
presence of retinol (Demetriou et al., 1984). Martire-Greco et al. observed the effect of vitamin 
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A on the LPS-induced post-sepsis immunosuppression in a mice model (Martire-Greco et al., 
2014). In the presence of atRA, she observed an increased recovery of the immunocompetence 
in these immunocompromised mice (Martire-Greco et al., 2014). Furthermore, recent studies 
have reported a decrease in the circulating concentration of antioxidant components of the host 
defence system in sepsis, including vitamin A, C, E and β-carotene (Ribeiro Nogueira et al., 
2009). Ribeiro Nogueira et al. monitored the serum level of retinol and β-carotene in septic 
patients admitted in ICUs in Brazil (Ribeiro Nogueira et al., 2009). He reported an important 
inadequacy of retinol and β-carotene in septic patients (Ribeiro Nogueira et al., 2009). He 
observed a significant lower level of β-carotene and higher level of CRP in septic patient 
without supplementation of vitamin A (Ribeiro Nogueira et al., 2009). These results might be 
an important hint for further prophylactic and therapeutic approaches for patients suffering from 
septic infections. Nevertheless, less is known about the effect and mechanism of vitamin A in 
fungal infections. Further studies are urgently needed. 
Beside the PRR-mediated antifungal host defence, the IFN I pathway has recently been 
demonstrated to play an important role in the anti-Candida host defence (Majer et al., 2012, 
Smeekens et al., 2013).  
The IFN-β response, induced by C. albicans either by activating the IFN I receptor or other 
receptors, like the TLRs or CLRs, initiates a complex antifungal host defence, including 
infiltration of innate immune cells to the place of inflammation to diminish the fungal pathogen 
load (Biondo et al., 2011, del Fresno et al., 2013, Smeekens et al., 2013).  
Controversial data have been published regarding the involvement of Dectin-1 in the IFN I 
response. While Bourgeois et al. showed that Dectin-1 seems not to be involved in the IFN-β 
response against Candida in DCs, del Fresno et al. showed a Dectin-1-dependent IFN-β release 
in DCs (Biondo et al., 2012, Bourgeois et al., 2011, del Fresno et al., 2013). Our results support 
the involvement of Dectin-1 in the IFN I response in human monocytes. 
The role of vitamin A in the IFN I pathway remains until now still unclear. We investigated the 
influences of atRA in the expression of IFN-β. We could demonstrate a downregulation of the 
C. albicans- and Dectin-1-mediated IFN-β response in the presence of atRA. In the next step, 
we investigated the function of atRA on the most important regulating factors in the IFN I 
signalling. We observed a significant atRA- mediated inhibitory effect on all of the C. albicans- 
upregulated IFN I regulating factors after 5 hours of incubation. Only the expression of the IFN 
I receptor (IFNAR1/2) was not altered in the presence of either C. albicans or C. albicans and 
atRA.  
  5. DISCUSSION 
89 
 
Although we observed a significant atRA-mediated downregulation of the IFN-β expression, 
we were unable to detect IFN-β in the supernatant. Nevertheless, IFN-β is known for its low 
expression levels in vivo and in vitro and thus remains below the detection limit at protein level 
(Majer et al., 2012). Nonetheless, we could verify a significant downregulation of the C. 
albicans and β-1.3 glucan-induced IFN-β mRNA expression in the presence of atRA.  
Besides IFNAR1, other receptors including the TLR7 and TLR9 have been reported to promote 
an IFN-β response by sensing fungal nucleic acids (Biondo et al., 2012, Bourgeois et al., 2011, 
He et al., 2013, Kasperkovitz et al., 2011).  
The TLR7 has been reported to play an essential part in the IFN-β response in C. albicans 
infection (Bourgeois et al., 2011, Naglik, 2014). The function of TLR9 in fungal infection is 
still not clear. It seems to be an important receptor for fungal recognition (Kasperkovitz et al., 
2011, van de Veerdonk et al., 2008). However, no increased susceptibility has been observed 
in TLR9 knockout mice (Kasperkovitz et al., 2011, van de Veerdonk et al., 2008). In our study, 
C. albicans inhibited the expression of both TLRs in human monocytes after 5 hours of 
stimulation, which has not been reported so far and might be another mechanism of C. albicans 
evading the host immune response (Bone, 1996, Comstedt et al., 2009). The presence of atRA 
lead to an increased downregulation of the TLR7, but did not alter the TLR9 expression. This 
is in agreement with Bourgeois et al., who reported that the TLR7-signalling promotes a pivotal 
role in the fungal pathogen recognition and mediates the IFN I signalling induced by a fungal 
pathogen (Bourgeois et al., 2011).  
In the next step, we investigated whether the IFN-β release by these specific TLRs might be 
modulated in the presence of atRA. For this purpose, we stimulated human PBMCs either with 
the specific TLR7-agonist, Imiquimod or the specific TLR9- agonist CPG Type A for 5 hours 
in the presence or absence of 1 μM atRA and measured the IFN-β expression on transcriptional 
level. The stimulation of each TLR leads to a significant increase in IFN-β mRNA expression. 
In the presence of atRA, the IFN-β mRNA expression was significantly downregulated. Taken 
together, our data show a huge impact of atRA on the IFN Type I signalling pathway and the 
expression of IFNβ. 
Although certain expression of IFN Type I has clearly shown to be necessary for an accurate 
immune response against C. albicans, an increased IFN-β release due to disseminated and 
invasive candidiasis can lead to a detrimental exaggerated host response (Majer et al., 2012).  
In this sense, Majer et al. reported a remarkable protection against invasive C. albicans 
infection in mice caused by a reduced recruitment of inflammatory myeloid cells (Majer et al., 
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2012). This data would support a potential protective effect of atRA on Candida-induced sepsis. 
Further in vivo studies are needed to confirm this hypothesis.





In the present work, we have demonstrated for the first time, that atRA plays an important 
modulatory role on the immune response of human monocytes against C. albicans. We 
observed that atRA is supressing the expression and release of the pro-inflammatory cytokines 
TNFα, IL6 and IL12b on transcriptional and posttranslational level in human monocytes 
challenged with C. albicans. Furthermore, we showed that atRA is able to modulate the 
expression of PRRs Dectin-1, TLR2, Gal-3 and TLR7 at transcriptional and posttranslational 
level, which are important mediators for the antifungal host defence.  
AtRA is also able to supress the Dectin-1-mediated pro-inflammatory cytokine expression of 
TNFα, IL6 and IL12b in human monocytes induced by β-glucan, a frequent PAMP on the cell 
wall of C. albicans. At least in part, this downregulation of the pro-inflammatory cytokine 
expression mediated by atRA could be related to the early modulation of Dectin-1 expression. 
Nevertheless, the main mechanism of atRA-mediated modulation of the immune response 
seems to be by a direct mode of action, since longer pre-incubation time reduced the inhibitory 
effect of atRA compared to the short pre-stimulation with atRA.  
Interestingly, vitamin A modulates another pathway, pivotal for C. albicans host defence, the 
IFN I pathway. We observed anti-inflammatory effect of atRA downregulating of the IFN-β 
expression as well as the expression of most of the important regulating factors known to be 
relevant in C. albicans infection. Furthermore, we observed a downregulation of the TLR7 gene 
expression, whereas TLR9 seems not to be altered. Both receptors located in the endosomal 
compartment recognize fungal nucleic acids after their internalization or phagocytosis, 
mediating an initiation of the IFN-β release and further IFN-β expression.   
All together we have demonstrated an important immunomodulatory role of vitamin A in 
human monocytes challenged with C. albicans.   
Further studies will help to understand the role of vitamin A in other cell lines of the innate and 
adaptive immune system in vitro. Furthermore, in vivo studies are urgently needed, since in 
vitro data only show a small item of the immune system. New investigations on vitamin A in 
C. albicans infection, realised in animal trials are already taking place in our research group. 
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